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Background: Mathematical models can be powerful policymaking tools. Simple, static models are 
user-friendly for policymakers. More complex, dynamic models account for time-dependent 
changes, but are complicated to understand and produce. Under which conditions are static models 
adequate? We compare static and dynamic model predictions of whether behavioural disinhibition 
could undermine the impact of HIV pre-exposure prophylaxis (PrEP) provision to female sex workers 
in South Africa.  
Methods: A static model of HIV risk was developed and adapted into a dynamic model. Both models 
were used to estimate the possible reduction in condom use, following PrEP introduction, without 
increasing HIV risk. The results were compared over a 20-year time-horizon, in two contexts: at 
epidemic equilibrium and during an increasing epidemic. 
Results: Over time-horizons of up to five years, the models are consistent. Over longer timeframes, 
the static model overstates the tolerated reduction in condom use where initial condom use is 
reasonably high (≥50%) and/or PrEP effectiveness is low (≤45%), especially during an increasing 
epidemic.  
Conclusions: Static models can provide useful deductions to guide policymaking around the 
introduction of a new HIV intervention over short-medium time-horizons of up to five years. Over 
longer timeframes, static models may not sufficiently emphasize situations of programmatic 






Mathematical models play an important role in policy making for public health.1–3 They can be used 
to assess the impact of different policy options, which may be impractical to test in implementation 
settings or over longer time horizons.1 Nonetheless, there is often hesitation among policy makers to 
rely on models, perceived to be an intimidating ‘black box’ process of uncertain applicability to real-
world settings.4,5 This may be owing to complexity in model structure, uncertainty around model 
assumptions or challenges in model communication.6 As a consequence, potentially useful models 
may be underemployed or in some cases inappropriately used to inform decision making.4 
Simple models have a comparative appeal for use in policy making. They can be used to deduce 
broad principles to guide decision-making through an approach that is easier for policy makers to 
understand and critique.7,4 For this reason, we previously used a simple, static model of HIV risk to 
assess the potential effect of behavioural disinhibition (in this case: reductions in the use of 
condoms) following the introduction of pre-exposure prophylaxis (PrEP) among female sex workers 
(FSW) in South Africa.8 Simple models have been used to obtain insights into a number of other 
pertinent HIV policy questions – from resource prioritization across low and middle income 
countries9 to the scale up of microbicides10,11, the cost-effectiveness of male circumcision in sub-
Saharan Africa12,13, declining HIV test positivity14 and projecting HIV diagnoses among children and 
adolescents in New York State15. 
To date there has been limited assessment of the conditions under which models of simple 
structural form are sufficient to guide policy making in HIV.16–20 A key element of modelling 
complexity is the extent to which model conclusions account for time-dependent changes. Static 
models take a snap-shot approach and cannot capture the downstream effects of population 
interaction. They are typically structurally more straightforward, and less data- and time-intensive to 
develop.21,22 By comparison, dynamic models account for changes over time owing to population 
interactions and evolving contextual factors. Dynamic models are typically represented by a system 
of differential or difference equations, evaluated numerically using programming tools with 
increased data requirements. 21,23 As a result, they are more time-intensive and expensive to devise 
and calibrate, and often require critical assumptions to be made about current and future trends.20,21  
Other key considerations in the design of models to inform policy making include the extent to 
which models can be devised, computed and appropriately interpreted by policy makers themselves, 
or whether external technical support is required.1,20,24 Simpler models, such as those calculated in 
Microsoft Excel, that can be developed and owned by policy makers themselves, may improve their 
uptake to inform decision making. However, accessibility needs to be balanced against the risk of 
inaccuracies through model over-simplification, leading to misleading model outcomes or 
interpretation, and the derivation of incorrect policy conclusions.2  
Modelling studies16,20,25,26 have proposed broad frameworks to guide the development of models for 
policy making, noting that models should adopt only the minimum level of complexity needed to 
appropriately represent the policy question at hand, in view of the availability of data, the 
importance of accounting for interactions between population groups, the time horizon of 
assessment and epidemiological context. However, none have given specific guidance around the 
characteristics or contexts in which simpler models suffice. Given that simple, static models form the 
basic building blocks for more complex models,22 it is important to determine conditions under 
which they can reliably provide an accessible approach to guide policy making. 
In 2009 Foss et al11 incorporated dynamic features into a static model of HIV risk10 to explore the 
impact of microbicide STI-efficacy. In 2014 Mishra et al17,27 assessed the static UNAIDS Modes of 
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Transmission model,9 used by many countries to prioritise HIV prevention interventions between 
groups at population-level. These studies11,17,27 concluded that by not capturing dynamic effects of 
partner interaction, the static model underestimates the contribution of epidemic drivers to HIV 
transmission over time. Other studies have used static and dynamic models to explore different 
aspects of a policy question but have not compared model outcomes.13,28 To the best of our 
knowledge, no study has examined the extent to which the conclusions of static models remain 
robust to the incorporation of dynamic effects over multiple time-horizons, when assessing the 
introduction of a new HIV intervention to a population group. 
To contribute to wider understanding of the role of simple, static models in decision making, we 
modify our previous model of HIV risk for female sex workers (FSW) in Hillbrow, South Africa8 to 
incorporate the dynamics of partner interaction over time. We assess the consistency of policy 
conclusions derived between the static and dynamic model formulations. We make this comparison 
over different time-horizons, as well as by HIV epidemic stage, to determine whether the underlying 
maturity of population epidemics affects the time-dependency of results. The introduction of PrEP 
for FSW in South Africa is a pertinent case study, in view of growing concerns around sub-optimal 
drug adherence29,30 and behavioural disinhibition,30,31 highlighting the need to understand trade-offs 





Model structures and parameterisation 
The static model was developed using the Bernoulli formulation of HIV risk,8 where the probability of 
HIV being transmitted through each sexual contact is an independent risk event. The sexual partners 
of FSW are assumed to come from a single population in which the proportion HIV infected is 𝑝𝑝. To 
assess the effect of changes in condom consistency following the introduction of PrEP, condoms 
were assumed to be used with consistency 𝛾𝛾0 prior to PrEP introduction and 𝛾𝛾1 after its 
introduction. As the relationship between PrEP adherence and effectiveness is yet to be defined for 
women,33 the model assumes an achieved level of PrEP use-effectiveness, 𝑏𝑏𝛼𝛼, corresponding to a 
level of PrEP adherence, 𝛼𝛼. The term ‘use-effectiveness’ is used to describe the HIV risk-reduction 
achieved through a level of use of an efficacious HIV prevention intervention (e.g. PrEP or condoms). 
A dynamic version of the static model was developed using difference equations, taking the 
Bernoulli risk formulation as the force of infection on FSW per timestep, and an equivalent 
formulation for male partner population. The dynamic model system allows prevalence to change 
over time as the proportion of HIV infected individuals, 𝐼𝐼/𝑁𝑁, where 𝐼𝐼 is the number of HIV infected 
individuals and 𝑁𝑁 the total population size.  
The dynamic model was fitted to HIV prevalence data for both FSW and partner populations 
between 1980 and 2014 using Monte Carlo methods with Latin Hypercube Sampling (R FME 
package34), run on 50,000 parameter sets. This yielded at least 200 fits for each scenario explored. 
Both models were coded in R programming environment and were parameterised and evaluated 
using the same set of fitted parameters, allowing for the evaluation of uncertainty ranges. PrEP was 
introduced in 2015 in line with its introduction to FSW in Hillbrow under the TaPS demonstration 
project.35 
 
Comparison between static and dynamic model outcomes 
The static and dynamic models were used to calculate two outcomes of interest in relation to 
behavioural disinhibition on PrEP: 
- Model Outcome 1: Lowest level of condom consistency tolerated on PrEP 
We used both models to explore the lowest level of condom use, 𝛾𝛾1∗, that FSW could drop to 
without increasing their HIV risk on PrEP. This lowest level of condom use is denoted: lowest level 
of condom consistency tolerated. For each model, the lowest level of condom consistency 
tolerated on PrEP was calculated using optimisation algorithms (dynamic model: R FME 
package34; static model: R rootSolve package36). 
 
- Model Outcome 2: Percentage reduction in condom consistency tolerated on PrEP 
These estimates of the lowest level of condom consistency tolerated were then used to calculate 
the percentage reduction in condom consistency (𝛾𝛾0 − 𝛾𝛾1∗)/𝛾𝛾0 that can be tolerated on PrEP 
without FSW’s HIV risk increasing. This measure allows policy makers to assess the relative 




To demonstrate how the two outcomes are related, consider a hypothetical case in which a FSW’s 
initial condom consistency is 80% and the lowest level of condom consistency tolerated (outcome 1) 
is 40%. Then, outcome 2, the percentage reduction in condom consistency tolerated on PrEP would 
be 50%.  
 
Accounting for different time horizons 
To assess how well the outcomes of the static and dynamic models match over longer time horizons, 
𝛾𝛾1∗, the lowest level of condom consistency tolerated on PrEP, was calculated using the dynamic 
model over time horizons of 3 months to 20 years. Three months was taken as the minimum time 
horizon in order to align with the 3-month period of evaluation of the static model (chosen to match 
the 3-monthly schedule of HIV tests required on PrEP to check for seroconversion30). Twenty years 
was taken as the maximum time horizon to be able to fully explore the differences between model 
outcomes over a longer period of time. 
 
Accounting for behavioural heterogeneity: differences in initial condom consistencies and PrEP use-
effectiveness  
Given the importance of accounting for heterogeneity in FSW’s initial condom consistencies,8,10 the 
parameter sets were fitted individually for initial condom consistencies (prior to introduction of 
PrEP) of 10%, 30%, 50% and 70%, spanning the range reported by this population.8  
As studies to date have been unable to relate the number of weekly doses of PrEP to levels of HIV 
risk reduction in women,37 we chose to span a spectrum of potential levels of PrEP use-effectiveness: 
25%, 45%, 65% and 85%. 85% was simulated as the highest level, as it equates to the maximum use-
effectiveness of condoms as in Grant and colleagues.8  
The lowest level of condom consistency tolerated on PrEP, without HIV risk increasing, was 
calculated across these levels of initial condom consistency and PrEP use-effectiveness.  
 
Accounting for stage of HIV epidemic 
To assess whether the results change by underlying stage of HIV epidemic, the analyses were 
repeated 20 years earlier, when the HIV epidemics in FSW and their partner populations were still 
increasing. Under this scenario, Increasing Epidemic, initial condom consistency, 𝛾𝛾0, was fixed in 
1994 and PrEP hypothetically introduced in 1995. This is in comparison to the base case analysis, 
Epidemic Equilibrium, where initial condom consistency was fixed in 2014 and PrEP introduced in 
2015 once the epidemics had started to stabilise.  
 
Additional analyses 
To assess whether the inclusion of antiretroviral treatment (ART), circumcision and sexually 
transmitted infections (STIs) in the models affected our conclusions, we conducted a model 
structural sensitivity analysis, removing all related parameters from the models and rerunning the 
analyses. To assess whether our conclusions were sensitive to PrEP being introduced when the 
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epidemics are fully endemic in the populations (Fully Endemic scenario), we repeated the analysis 
with PrEP introduced in 2030. 
 
Comparison of qualitative policy conclusions between static and dynamic models 
In order to explore the contexts in which the qualitative conclusions made on the basis of static 
models may be appropriate to guide HIV policy making, we assessed the robustness of the policy 
conclusions derived from the static model compared to those derived from the dynamic model. The 
qualitative policy conclusions derived from the static model were outlined in our previous study, 
however they were deduced using a static model only, and not substantiated using a dynamic model 
formulation.8 
 








The lowest levels of condom consistency that can be tolerated by FSW on PrEP (without their HIV 
risk increasing) at Epidemic Equilibrium and in the context of an Increasing Epidemic, are shown in 
Figure 1 and Figure 2 respectively.  
In Figures 1 and 2, the three rows, from top to bottom, represent FSW initial condom consistencies 
(at point of introduction of PrEP) of 30%, 50% and 70% respectively. The three columns represent, 
from left to right, PrEP use-effectiveness of 25%, 45% and 65% respectively. For each combination of 
initial condom consistency and PrEP use-effectiveness, boxplot graphs depict the lowest level of 
condom consistency tolerated on PrEP (vertical-axis). The far-left boxplot on the horizontal-axis of 
each of the graphs is the lowest level of condom consistency estimated using the static model. The 
boxplots to the right of it are the lowest level of condom consistencies estimated using the dynamic 
model, at time points of 3 months, 1 year, 2 years, 5 years, 10 years and 20 years, from left to right. 
The boxplots depict uncertainty in the estimated lowest level of condom consistency tolerated, with 
the black line representing the median value, the coloured section the interquartile range (25-75% of 
the values) and the whiskers the maximum and minimum values. The differences between the static 
and dynamic model outcomes can be understood by comparing how similar the lowest level of 
condom consistency estimated by the static model is to the lowest level of condom consistency 
estimated by the dynamic model over time.  
Whilst Figures 1 and 2 depict the key trends in model differences for each scenario, more detailed 
plots including FSW initial condom consistency of 10% and PrEP use-effectiveness of 85% are shown 
in Supplementary Materials, Figures S5 and S7 for the Epidemic Equilibrium and Increasing Epidemic 
scenarios respectively. The Supplementary Materials also contain the equivalent boxplot graphs for 
the second model outcome: percentage reduction in condom consistency tolerated on PrEP 
(Supplementary Materials Figures S6 and S8), the model fits to HIV prevalence (Supplementary 
Materials Figures S1-S4), as well as all underlying data (Supplementary Materials Tables S2-S10). 
 
Comparison of static and dynamic model outcomes 
Under the scenario that PrEP is introduced at Epidemic Equilibrium, the percentage reductions in 
condom consistency estimated by the static and dynamic models are very similar up to a time-
horizon of one year. By five years, the model predictions remain consistent to within 25% relative 
difference between medians (<35% between credible intervals (CrIs)), and by 20 years to within 35% 
between medians (≤100% between CrIs) (Supplementary Materials Table S2a). The differences 
between the percentage reductions in condom consistency predicted by the static and dynamic 
models are less consistent over time where initial condom consistency is higher (≥50%) and PrEP 
use-effectiveness is lower (≤45%). This is consistent with our previous work based on the static 
model, which indicated that reductions in condom consistency should be of greatest concern for 
FSW with high initial condom consistencies achieving low levels of PrEP use-effectiveness8. However, 
the results suggest that the magnitude of concern predicted by the static model was understated 
over the long-term. 
Under the Increasing Epidemic scenario, the differences between the percentage reductions in 
condom consistency predicted by the models are more pronounced over time. By five years the 
relative difference between model medians is less than 10% (<25% between CrIs) at high levels of 
PrEP use-effectiveness (85%) but up to 100% (100% between CrIs) at low levels of PrEP use-
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effectiveness (25%). By 20 years, the differences between the models start to decrease in response 
to the natural plateau of the underlying epidemics (Supplementary Materials Table S2b).  
For both epidemic scenarios, removing ART, circumcision and STIs from the models under the 
structural sensitivity analysis led to bigger differences between model outcomes in situations where 
PrEP use-effectiveness is low (≤45%) and initial condom consistency is at least 30% (<45% relative 
difference between CrIs by 5 years, and <50% relative difference by 20 years) (Supplementary 
Materials Tables S3a and Sb, Figures S9-S12). Introducing PrEP in 2030 under the Fully Endemic 
rather than in 2015 in the Epidemic Equilibrium scenario led to differences under the same 
situations, although the magnitude of differences was smaller (<25% relative difference between 
CrIs by 5 years, and <35% between by 20 years) (Supplementary Materials Table S4, Figures S13 and 
S14). Additional analysis comparing the model outcomes by scenario is set out in Supplementary 
Materials, Additional Assessment of Results section. 
 
Comparison of policy conclusions between static and dynamic models 
To explore the contexts in which the qualitative conclusions made on the basis of static models may 
be appropriate to guide HIV policy making, we list three policy conclusions derived based on the 
static model8, and assess their validity under dynamic model formulation. 
1. Condom use can be reduced to zero without increasing HIV risk, if the level of HIV risk reduction 
achieved through PrEP is at least high as the maximum risk reduction possible through condom use 
This conclusion holds under the dynamic model in the Epidemic Equilibrium scenario, as well as in 
the Increasing Epidemic scenario, other than at high levels of initial condom consistency (70%), 
where after five years the dynamic model predicts that a reduction in condom consistency to zero 
may start to lead to an increase in HIV risk (Figures 1 & 2; Supplementary Materials Table S2a &S2b 
and Figures S6 & S8). 
 
2. Reductions in condom consistency are especially well tolerated where:  
i. Higher levels of PrEP use-effectiveness are achieved (e.g. ≥65%) 
Figure 3 shows the lowest levels of condom consistency tolerated calculated using the static and 
dynamic models for PrEP use-effectiveness levels of 65% and 85%. The lowest levels of condom 
consistency are shown for initial condom consistencies of 10% (in blue), 30% (in orange), 50% (in 
pink), and 70% (in green). The dotted lines represent median estimates and shaded areas 
represent the 95% CrIs. The top row depicts the Epidemic Equilibrium scenario, and bottom row 
the Increasing Epidemic scenario. 
 
With PrEP use-effectiveness of at least 65%, the static model predicts that median reductions in 
condom use of at least 85% will be possible without increasing HIV risk. The dynamic model 
broadly supports this conclusion, with less than 25% relative difference between the model 
medians and CrIs after five years, and less than 35% relative difference after 20 years in the 
Epidemic Equilibrium scenario. Importantly, under the Increasing Epidemic scenario, these 
differences are much more pronounced, with up to 60% relative difference between medians 





For initial condom consistencies of up to 50%, the static model predicts that FSW on PrEP with 
use-effectiveness of at least 65% can stop using condoms completely without increasing HIV risk. 
This is consistent with the dynamic model conclusions under the Epidemic Equilibrium scenario. 
Under the Increasing Epidemic scenario, this only holds where PrEP use-effectiveness is at least 
85% (rather than 65%) (Figure 3; Supplementary Materials Table S2a & Sb).  
 
ii. Or where initial condom consistencies are low (e.g. <50%). 
Figure 4 shows the lowest levels of condom consistency tolerated after PrEP introduction, 
calculated using the static and dynamic models for initial condom consistencies (before PrEP 
introduction) of 10% and 30%. The lowest levels of condom consistency tolerated are shown 
corresponding to PrEP use-effective of 25% (in green), 45% (in pink), 65% (in orange), and 85% 
(in blue). The dotted lines represent median estimates and shaded areas represent the 95% CrIs. 
The top row depicts the Epidemic Equilibrium scenario, and bottom row the Increasing Epidemic 
scenario. 
 
Under the Epidemic Equilibrium scenario the dynamic model supports the outcomes of the static 
model especially well in the short term, with relative difference between medians of less than 
5% after five years (<25% between the 95% CrIs), and less than 5% relative difference by 20 
years (<70% between 95% CrIs). Under the Increasing Epidemic scenario, the model differences 
are large over time, e.g. estimates from the dynamic model of the lowest level of condom 
consistency tolerated are up to double the levels estimated by the static model after 5 years  
(Figure 4; Supplementary Materials Table S2a & S2b). 
 
3. Even with the achievement of low levels of PrEP use-effectiveness (e.g. ≤45%), reductions in 
condom consistency are possible without increasing HIV risk.  
As with the static model, under the Epidemic Equilibrium scenario the dynamic model predicts that 
some decreases in condom consistency on PrEP will always be possible without increasing HIV risk 
over the 20-year time horizon, even for lower levels of PrEP use-effectiveness of up to 45%. This 






Main findings of this study 
This study demonstrates that there are contexts in which static models can provide useful 
deductions to guide policy making around the introduction of a new HIV intervention. Static models 
may have advantages to guide programming over short-medium time horizons in certain settings. 
However, over longer timeframes, static models may not sufficiently emphasize situations of 
programmatic importance, especially in contexts where underlying epidemics are not at equilibrium. 
PrEP is likely to be of benefit in reducing HIV risk in high-burden settings, even if moderate 
reductions in condom use occur. 
 
What is already known on this topic 
It is well established that dynamic models are more appropriate to address policy questions where it 
is important to account for the downstream effects of population interactions and evolving 
contextual factors over time.4,5,25,26 Both static and dynamic models have been used to inform policy 
making in the field of HIV.9,10,12,38,39 Existing studies have cautioned that static models may 
underestimate the contribution of epidemic drivers to HIV transmission over time.17,27 However, to 
date, no study has assessed the epidemic contexts and timeframes over which simple static models 
may suffice to inform decision making in the field of HIV, especially in the context of the introduction 
of new prevention interventions. 
 
What this study adds 
This study compares the outcomes of a static model with the outcomes of a matched dynamic 
model, applied to different epidemic contexts across time horizons. Both models are used to assess 
the absolute and percentage reductions in condom consistency that can be tolerated, without HIV 
risk increasing, following introduction of PrEP for FSW. We found that over short-medium time-
horizons of up to five years, the static model approximates the outcomes of the dynamic model 
fairly consistently. Over longer timeframes of up to 20 years, there are contexts in which the 
reductions in condom use predicted by the static model do not hold under the dynamic model 
formulation; particularly where initial condom consistency is reasonably high (≥50%) and/or PrEP 
use-effectiveness is low (≤45%). The differences between the two models are greater where the 
underlying HIV epidemic is increasing (Figure 1 & 2, Supplementary Materials Tables S2a & S2b). The 
structural sensitivity analysis (removing model parameters relating to ART, circumcision and STIs) 
showed bigger differences between model outcomes in situations where PrEP use-effectiveness is 
low (≤45%) and initial condom consistency is at least 30%. Introducing PrEP where the underlying 
HIV epidemic is fully endemic in 2030 (rather than at equilibrium in 2015) led to differences under 
the same situations, although smaller in magnitude. The difference between the models’ outcomes 
arise predominantly from the dynamic model’s ability to capture changes in HIV prevalence over 
time, which is highlighted where PrEP use-effectiveness is insufficiently high enough to mask greater 
reductions in condom use. 
Nonetheless, the broad-stroke policy conclusions predicted by the static model hold under the 
dynamic model formulation. Specifically, in high HIV burden contexts, PrEP for FSW is likely to be of 
benefit in reducing HIV risk even if reductions in condom use occur; that reductions in condom 
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consistency can be better tolerated by FSW achieving high levels of PrEP effectiveness or with low 
baseline condom consistencies; and efforts to promote condom use will be especially critical for FSW 
with high levels of baseline condom consistency but who are anticipated to adhere less well to PrEP.  
Simple, static models have a structural advantage over dynamic models, as they can usually be more 
easily analytically manipulated to deduce conclusions to guide policy making. These take-aways are 
often additional to those that can be gleaned through numeric and graphic assessment of either 
model’s outcomes. Noting that model results are usually discounted over longer time-horizons due 
to uncertainty in underlying assumptions or implementation contexts, there may be merits for using 
static models to guide the introduction of new HIV interventions over short-medium time horizons, 
especially where the underlying HIV epidemic is well-evolved. Static models may also be better 
suited to guide the roll out of interventions intended for short term-use, such as PrEP, which is 
intended to cover seasons of risk.30 
In contexts with increasing epidemics, dynamic models may be more appropriate to guide the 
programming of interventions for long-term use. Building on the conclusions in Mishra and 
colleagues,17 this study underscores that decision maker reliance on the magnitude of intervention 
effectiveness assessed through static models, such as the UNAIDS Modes of Transmission model,9 
should be cautioned in contexts where HIV prevalence is increasing, e.g. in the relevant sub-
epidemics in Eastern Europe, South East Asia, the Middle East and South America, especially in 
relation to high burden (e.g. key) populations.  
Future studies could extend this model comparison to other infectious diseases to understand the 
conditions under which static models are sufficient to inform policy making. This may be especially 
pertinent for diseases where there is limited understanding of key components required in dynamic 
model construction (e.g. transmission dynamics or their quantification), but comparably better 
understanding of the narrower information set needed to formulate static models. 
Limitations of this study 
There are several limitations to this study. The models used in this analysis are simplified 
formulations of static and dynamic models, to facilitate comparison. They do not account for 
different levels of PrEP coverage or population heterogeneity, relying instead on population 
averages. For the same reason, these two populations were explored in isolation without accounting 
for interactions with wider societal groups. Assessment of the effects of behavioural disinhibition are 
limited to FSW, not the downstream effects on partner populations. 
The analysis does not explicitly explore potentially important correlations between risk factors and 
PrEP effectiveness. However, the impact of correlations between initial condom consistency and 
PrEP adherence can be easily deduced through the scenarios explored (Figures 1 & 2). 
The data used to characterise the FSW and their partner population in Hillbrow, South Africa, is 
limited by age and in some cases reliance on self-reports of sexual behaviour, which are susceptible 
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Figure 1: Boxplots showing the lowest level of condom consistency tolerated on PrEP (for HIV risk not to increase) predicted through the static and dynamic models – PrEP introduced at 
HIV Epidemic Equilibrium. The results are shown distinctly for initial condom consistencies (at point of introduction of PrEP) of 30%, 50% and 70%, and simulated for levels of achieved PrEP 
use-effectiveness at HIV risk reduction of 25%, 45% and 65%. In the case of the static model, the lowest levels of condom consistency tolerated on PrEP are point estimates. In the case of the 
dynamic model, the lowest levels of condom consistency tolerated on PrEP are given after 3 months, 1 year, 2 years, 5 years, 10 years and 20 years on PrEP. The boxplots depict uncertainty in 





Figure 2: Boxplots showing the lowest level of condom consistency tolerated on PrEP (for HIV risk not to increase) predicted through the static and dynamic models – PrEP introduced with 
Increasing Epidemic. The results are shown distinctly for initial condom consistencies (at point of introduction of PrEP) of 30%, 50% and 70%, and simulated for levels of achieved PrEP use-
effectiveness at HIV risk reduction of 25%, 45% and 65%. In the case of the static model, the lowest levels of condom consistency tolerated on PrEP are point estimates. In the case of the 
dynamic model, the lowest levels of condom consistency tolerated on PrEP are given after 3 months, 1 year, 2 years, 5 years, 10 years and 20 years on PrEP. The boxplots depict uncertainty in 





Figure 3: Lowest level of condom consistency tolerated at higher levels of PrEP use-effectiveness, for both scenarios Epidemic Equilibrium and Increasing Epidemic. The lowest levels of 
condom consistency tolerated on PrEP are depicted for PrEP use-effectiveness levels of 65% (left) and 85% (right). Each graph shows the lowest level of condom consistency estimated by the 
static model, and by the dynamic model over a time horizon of 3 months to 20 years, corresponding to initial condom consistencies of 10%, 30%, 50% and 70%. The first row of graphs 
corresponds to the scenario Epidemic Equilibrium and the second row of graphs corresponds to the scenario Increasing Epidemic. The dotted lines are median estimates and shaded areas are 
95% CrIs (colour coding in legend).  Where the median results corresponding to lower initial condom consistencies cannot be seen on the graph, it indicates that the estimated lowest level of 





Figure 4: Lowest level of condom consistency tolerated at lower levels of initial condom consistency, for both scenarios Epidemic Equilibrium and Increasing Epidemic. The lowest levels of 
condom consistency tolerated on PrEP are depicted for initial condom consistencies of 10% (left) and 30% (right). Each graph shows the lowest level of condom consistency estimated by the 
static model, and by the dynamic model over a time horizon of 3 months to 20 years, corresponding to PrEP use-effectiveness levels of 25%, 45%, 65% and 85%. The first row of graphs 
corresponds to the scenario Epidemic Equilibrium and the second row of graphs corresponds to the scenario Increasing Epidemic. The dotted lines are median estimates and shaded areas are 
95% CrIs (colour coding in legend).  Where the median results corresponding to specific levels of PrEP effectiveness cannot be seen on the graph, it indicates that the lowest level of condom 
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Static formulation of HIV risk 
Consistent with our previous work,1 the static model of HIV risk takes the Bernoulli formulation, where the 
probability of the HIV virus being transmitted through each sexual contact is treated as an independent risk 
event. In our simplified population model, and to facilitate comparison between the static and dynamic models, 
female sex workers (FSW) are assumed to have a single partner population ‘male partners’, in which the 
proportion HIV infected is 𝑝𝑝. For simplicity, male partners are characterised as clients, rather than other partner 
types (such as regular partners). For a given time period, ℎ, FSW are assumed to have 𝐶𝐶𝑚𝑚 0F* partners, with whom 
they have an average of 𝑛𝑛𝑚𝑚 sex acts each. ℎ is taken as 3 months, corresponding to the minimum period after 
which an individual on PrEP must return to the provider to perform an HIV test to check for seroconversion 
(amongst other indicators).2 We assume an average probability of HIV transmission, 𝛽𝛽𝑓𝑓, per sexual contact with 
an HIV infected male partner. It is assumed that all sex acts are peno-vaginal on the basis of available 
epidemiological data for FSW in Hillbrow.3  
To assess the effect of any change in condom consistency (average proportion of sex acts in which a condom is 
used) following the introduction of PrEP, condoms are assumed to be used with consistency 𝛾𝛾0 prior to PrEP 
introduction and 𝛾𝛾1 after its introduction. We assume condoms to have an HIV risk reduction efficacy, 𝜀𝜀, 
including slippage and breakage. The exact relationship between adherence and effectiveness of PrEP remains 
under investigation, especially for women.4 As such, the equations assume an overall achieved level of ‘PrEP 
use-effectiveness’, 𝑏𝑏𝛼𝛼, corresponding to a given level of FSW PrEP adherence, 𝛼𝛼. In its most basic formulation, 
the Bernoulli model of HIV risk to FSW is: 
𝜋𝜋 = 1 − �𝑝𝑝 � 1 − 𝛽𝛽𝑓𝑓(1 − 𝑏𝑏𝛼𝛼)(1 − 𝜀𝜀𝛾𝛾)�
𝑛𝑛 𝑚𝑚
+ (1 − 𝑝𝑝)�
𝐶𝐶𝑚𝑚
  
Where γ = γ0 before the introduction of PrEP, and γ1 after the introduction of PrEP.  
1.1 
To account for changes in HIV risk owing to increased sexually transmitted infection (STI) exposure resulting 
through a decrease in condom consistency, it is assumed that 𝑠𝑠1, the probability that at least one person in the 
partnership has an STI following the introduction of PrEP, increases proportionally to the absolute change in 
condom consistency; in other words 𝑠𝑠1 = 𝑠𝑠0�1 + (𝛾𝛾0 − 𝛾𝛾1)�, where 𝑠𝑠0 is the probability that at least one person 
in the partnership has an STI prior to the introduction of PrEP. Parameter 𝛿𝛿 is the multiplicative increase in per 
sex act probability of HIV transmission in the presence of an STI.  
To account for antiretroviral (ART) coverage and male circumcision levels in this setting, 𝜗𝜗𝑚𝑚 is taken as the 
proportion of HIV+ partners that are on ART and 𝜚𝜚 is the average reduction in the probability of HIV 
                                                          
* Static model parameters are denoted subscripts - f (for female) and m (for male) - as relevant, for ease of comparability with parameters in 
the dynamic model. 
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transmission due to viral suppression on ART. The proportion of male population circumcised is denoted by  𝜏𝜏 
and 𝜎𝜎𝑓𝑓is the average reduction in probability HIV transmission to women, when the male partner has been 
circumcised.  
Thus the HIV risk to a FSW, for a 3-month timestep, is given by the static model: 














(1 − 𝜗𝜗)𝑠𝑠 � 1 − 𝛿𝛿𝛽𝛽𝑓𝑓(1 − 𝑏𝑏𝛼𝛼)(1 − 𝜀𝜀𝛾𝛾)�
𝑛𝑛
+(1 − 𝜗𝜗)(1 − 𝑠𝑠) � 1 − 𝛽𝛽𝑓𝑓(1 − 𝑏𝑏𝛼𝛼)(1 − 𝜀𝜀𝛾𝛾)�
𝑛𝑛
+𝜗𝜗𝑠𝑠 � 1 − (1 − 𝜚𝜚)𝛿𝛿𝛽𝛽𝑓𝑓(1 − 𝑏𝑏𝛼𝛼)(1 − 𝜀𝜀𝛾𝛾)�
𝑛𝑛














(1 − 𝜗𝜗)𝑠𝑠 � 1 − (1 − 𝜎𝜎)𝛿𝛿𝛽𝛽𝑓𝑓(1 − 𝑏𝑏𝛼𝛼)(1 − 𝜀𝜀𝛾𝛾)�
𝑛𝑛
+(1 − 𝜗𝜗)(1 − 𝑠𝑠) � 1 − (1 − 𝜎𝜎)𝛽𝛽𝑓𝑓(1 − 𝑏𝑏𝛼𝛼)(1 − 𝜀𝜀𝛾𝛾)�
𝑛𝑛
+𝜗𝜗𝑠𝑠 � 1 − (1 − 𝜎𝜎)(1 − 𝜚𝜚)𝛿𝛿𝛽𝛽𝑓𝑓(1 − 𝑏𝑏𝛼𝛼)(1 − 𝜀𝜀𝛾𝛾)�
𝑛𝑛









With γ = γ0 before the introduction of PrEP, and γ1 after the introduction of PrEP; 
s = s0 before the introduction of PrEP and s1 after the introduction of PrEP; 
And s1 = s0(1 + (  γ0 −   γ1)). 
1.2 
Dynamic formulation of HIV risk 
The static model was evolved into dynamical system through difference equation structure, taking the Bernoulli 
risk formulation (1.2) as the force of infection on FSW, and an equivalent Bernoulli risk formulation of HIV risk 
as the force of infection on the male partner population. Here, the male partner population, for the time period, 
ℎ, are assumed to have 𝐶𝐶𝑓𝑓  partners, with whom they have an average of 𝑛𝑛𝑓𝑓 sex acts each. We assume an average 
probability of HIV transmission, 𝛽𝛽𝑚𝑚, per sexual contact with an HIV infected FSW partner. No male partners 
are assumed to be taking PrEP. Parameter 𝜗𝜗𝑓𝑓 is the proportion of HIV positive FSW that are on ART and 𝜎𝜎𝑚𝑚is 
the average reduction in probability of HIV transmission to men, when the man himself has been circumcised. 
The dynamic HIV compartmental model divides the population, of size N, into susceptible individuals S and 
HIV infected individuals, I. Instead of a static HIV prevalence, 𝑝𝑝, for each population, the dynamic model 
system allows prevalence to change over time as the proportion of HIV infected individuals, 𝜆𝜆 = 𝐼𝐼/𝑁𝑁. The 
model is run from 1980 to 2035, with initial prevalence of HIV at the start of the epidemic in 1980 of 𝑝𝑝𝑓𝑓0in FSW 
and 𝑝𝑝𝑚𝑚0  in male partners. PrEP is introduced for FSW in 2015 under the Epidemic Equilibrium (i.e. steady 
state) scenario, and retrospectively in 1995 under the Increasing Epidemic scenario where the HIV epidemics in 
FSW and their male partners are still increasing (i.e. transient state). 
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The dynamic model system assumes an underlying population mortality rate 𝜇𝜇𝑓𝑓 and 𝜇𝜇𝑚𝑚 in FSW and male 
partners respectively, as well as a rate of AIDS-related deaths of 𝜉𝜉𝑓𝑓 and 𝜉𝜉𝑚𝑚 in FSW and male partners 
respectively. The rate of recruitment into both populations are taken as the population growth rates 𝜃𝜃𝑓𝑓 and 𝜃𝜃𝑚𝑚 
respectively. 
As little is known about the rate of increase in condom consistency in these populations over time, change in 
condom consistency from the start of the HIV epidemic is approximated by a linear increase in consistency 
between 1980 and the year prior to the introduction of PrEP (2014 for the Epidemic Equilibrium analyses, and 
1994 for the Increasing Epidemic analyses).  
To account for changes in ART coverage over time, in the dynamic model, ART coverage is taken to be zero 
between 1980 and 2003. Linear scale up assumed from 2003, in line with the wide-scale introduction in South 
Africa5,6 in 2003, to levels in 2012 for male partners7 and 2014 for FSW8 (these being the latest available data 
for each population to parameterise the model up to the final point of fitting in 2014). 
We account for changes in male circumcision levels in the context of the 2007 WHO and UNAIDS guidance on 
scale up voluntary male circumcision levels for HIV prevention9 and the 2010 South African government  
introduction of their VMMC policy and programme.7 Due to the limited data availability on circumcision levels 
in Hillbrow (or by proxy, Gauteng, the South African Province in which it lies), with national survey data only 
available for 200310 and 20127, we therefore assume that circumcision levels are constant at 2003 levels between 
1980 and 2003, and that they increase linearly to 2012 levels and are constant thereafter (likewise as these are 
the latest available data to parameterise the model up to the final point of model fitting in 2014). 
The equations used for the dynamical system formulation are given by:  
 
Force of infection to FSW from male partners 





   
2.1 
Force of infection to male partners from FSW 






  and: 




�1 − 𝜗𝜗𝑓𝑓�𝑠𝑠� 1 − 𝛿𝛿𝛽𝛽𝑚𝑚(1 − 𝜀𝜀𝛾𝛾)�
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𝑛𝑛𝑓𝑓
+𝜗𝜗𝑓𝑓𝑠𝑠� 1 − (1 − 𝜎𝜎𝑚𝑚)(1 − 𝜚𝜚)𝛿𝛿𝛽𝛽𝑚𝑚(1 − 𝜀𝜀𝛾𝛾)�
𝑛𝑛𝑓𝑓










𝑁𝑁𝑚𝑚 = 𝑆𝑆𝑚𝑚 + 𝐼𝐼𝑚𝑚 
𝑁𝑁𝑓𝑓 = 𝑆𝑆𝑓𝑓 + 𝐼𝐼𝑓𝑓 
2.3 
Balancing equation 
𝐶𝐶𝑓𝑓 = 𝐶𝐶𝑚𝑚𝑁𝑁𝑓𝑓/𝑁𝑁𝑚𝑚 
2.4 
Difference Equations 
𝑆𝑆𝑓𝑓 𝑡𝑡+1 = 𝜃𝜃𝑓𝑓𝑁𝑁𝑓𝑓 0 + 𝑆𝑆𝑓𝑓 𝑡𝑡 − Π𝑚𝑚𝑆𝑆𝑓𝑓 𝑡𝑡 − 𝜇𝜇𝑓𝑓𝑆𝑆𝑓𝑓 𝑡𝑡  
𝐼𝐼𝑓𝑓 𝑡𝑡+1 = 𝐼𝐼𝑓𝑓 𝑡𝑡 + Π𝑚𝑚𝑆𝑆𝑓𝑓 𝑡𝑡 − (𝜇𝜇𝑓𝑓 + 𝜉𝜉𝑓𝑓)𝐼𝐼𝑓𝑓 𝑡𝑡 
 
𝑆𝑆𝑚𝑚 𝑡𝑡+1 = 𝜃𝜃𝑚𝑚𝑁𝑁𝑚𝑚 0 + 𝑆𝑆𝑚𝑚 𝑡𝑡 − Π𝑓𝑓𝑆𝑆𝑚𝑚 𝑡𝑡 − 𝜇𝜇𝑚𝑚𝑆𝑆𝑚𝑚 𝑡𝑡  
𝐼𝐼𝑚𝑚 𝑡𝑡+1 = 𝐼𝐼𝑚𝑚 𝑡𝑡 + Π𝑓𝑓𝑆𝑆𝑚𝑚 𝑡𝑡 − (𝜇𝜇𝑚𝑚 + 𝜉𝜉𝑚𝑚)𝐼𝐼𝑚𝑚 𝑡𝑡  
2.5 
 
Implementation context: FSW community in Hillbrow, South Africa, and PrEP 
This comparison is undertaken at a time when PrEP has been demonstrated effective for populations at 
substantial risk of HIV.11 However concerns around sub-optimal adherence12,13 and behavioural disinhibition14,15 
have led to interest in understanding the trade-offs associated with PrEP implementation outside of trial 
settings.16,17 Hillbrow is a pertinent setting for this assessment; a context with 72% HIV prevalence among FSW 
8 and high prevalence among partner populations.18,19 PrEP has been rolled out for FSW in South Africa under 
the National Sex Worker HIV Plan (2016-2019),20 however challenges in PrEP retention were observed in 
TaPS,21 a 2015-2017 PrEP and early antiretroviral treatment (ART) demonstration project among the Hillbrow 
FSW community. Given the challenges FSW face in negotiating condom use22 and the financial incentives for 
condomless sex with clients23, this is a timely case study, which we hope will contribute to decision makers’ 





Structural sensitivity analysis 
To assess whether the inclusion of ART, circumcision and STIs in the models affects their conclusions, we 
conducted a model structural sensitivity analysis by rerunning the analyses, having removed all parameters 
relating to: the reduction in HIV transmission on ART and ART coverage; the reduction in HIV transmission in 
peno-vaginal sex when the male partner is circumcised and the proportion of the male partner population that is 
circumcised; and the multiplicative increase in per sex act in the probability of HIV transmission in the presence 
of an STI and the probability at least one person in the partnership has an STI. 
 
Fully Endemic scenario 
To assess whether there is a significant difference in the model comparisons when PrEP is implemented when 
the HIV epidemics have fully endemic in the populations, in comparison to when they first reach equilibrium, 
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Model parameterization  
The data and data sources used in the parameterisation and fitting of the models are set out in Table S1 below. Behavioural and epidemiological data are taken from 
Hillbrow, Johannesburg, where available, otherwise extrapolated from consistent high HIV burden contexts in South Africa.  
Parameter Symbol Estimate Low High  References 
Proportion of male partner 
population HIV infected 
𝑝𝑝𝑚𝑚 
 
0.02 0.0 0.05 There are significant challenges in identifying prevalence in 
clients of sex workers. As such, it is approximated by 
prevalence in migrant workers, an established client group 
of FSW in sub-Saharan Africa.24 
Year: 1980 
At the start of the epidemic, males are assumed (owing to 
lack of data) to have very low prevalence of HIV, between 
the values stated 
  0.259 0.203 0.325 Year: 2000 
Migrant workers, male, from KwaZulu-Natal, South 
Africa.25 
Low and high estimates are calculated as 95% CI from 
underlying data assuming binomially distributed. 
  0.339 0.275 0.410 Year: 2004 
Non-residents (study proxy for migrant work), men, from 
KwaZulu-Natal, South Africa.26 





0.05 0.0 0.1 Year: 1980 
At the start of the epidemic, males are assumed (owing to 
lack of data) to have very low prevalence of HIV, between 
the values stated 
  0.45 0.3891956  
 
0.5123358 Year: 1997 
FSW, Johannesburg, South Africa.27 
Low and high estimates are calculated as 95% CI from 
underlying data assuming binomially distributed. 
  0.718 0.565 0.812 Year: 2014 
FSW Johannesburg, South Africa.8 
Initial condom consistency with 
partners 
𝛾𝛾0 0.05 0.0 0.1 Year: 1980 
At the start of the epidemic, condoms are assumed (owing to 
lack of data) to be used at very low levels, between the 
values stated. 























Data used to inform the range of initial condom 
consistencies simulated in the analysis. 
Probability at least one person 
in the partnership has an STI 
𝑠𝑠0 0.21 0.15 0.3 Owing to limited data for this population, STI prevalence 
data is taken where available in relation to specific HIV-
transmission increasing STIs28, and otherwise in relation to 
STI prevalence in general: 
Estimate: Prevalence of Neisseria gonorrhoea in Hillbrow 
FSW.29 
Low Estimate: Prevalence of Chlamydia trachomatis & 
Neisseria gonorrhoea in Hillbrow FSW.30  
High Estimate: FSW STI prevalence, Durban.31  
Proportion of HIV+ partner 
population on ART 
𝜗𝜗𝑚𝑚 0.257 0.212 0.308 Proportion of South African males having accessed 
treatment, 2012.7 
Proportion of HIV+ HRW 
women population on ART 
𝜗𝜗𝑓𝑓 0.234 0.506 0.088 Current ART status, FSW, Johannesburg, South Africa, 
2014.8 
Number of generic male 
partners, per 3 month period 
𝐶𝐶𝑚𝑚 106 78 128 Sum of: 
Mean monthly reported number of clients per FSW, 
Hillbrow; multiplied by 3, i.e. 105 (78-126);32 and  
Number of main sexual partners, FSW Hillbrow, i.e. 1 
(0.37-2).33  
Number of males’ female 
partners, per 3 month period 
𝐶𝐶𝑓𝑓 4.5 2.97 6.75 Average number of sex partners for high risk men in control 
arm.34  
Low and high estimates are calculated as 95% CI from 
underlying data assuming binomially distributed. 
Average number of sex acts – 
with generic male partners, per 
3 month period 
𝑛𝑛𝑚𝑚 1.2  1.05 1.74 Weighted (by number of clients and number of main sexual 
partners stated in calculation of 𝐶𝐶𝑓𝑓) average of: 
- Number of sexual encounters per client, Hillbrow (1-1.2),30 
and   
- Mean monthly frequency of sex acts in main partnerships, 
Hillbrow, multiplied by 3: 24 (mid-point) (12-36).32 
Average number of males’ sex 
acts – with female partner, per 3 
month period 
𝑛𝑛𝑓𝑓 6.3 4.5 9.0 Average frequency of sex acts in casual partnerships for 
people with high sexual activity, per month 2.1 (1.5 – 3.0), 
multiplied by 3.30 
% male population circumcised 𝜏𝜏 0.252 0.159 0.376 Year: 2003 
Men 15-59 years, Gauteng Province.10 
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Parameter Symbol Estimate Low High  References 
Low and High Estimates are calculated as 95% CI from 
underlying data assuming binomially distributed. 
  0.482 0.442 0.522 Year: 2012 
Adult males, Gauteng Province.7 
Condom HIV risk reduction 
efficacy per sex act 
𝜀𝜀 0.85 0.9 0.8 Midpoint:35 (with consistent use),36 (with consistent use) 
Probability of HIV 
transmission, male to female, 
through peno-vaginal sex 
𝛽𝛽𝑓𝑓 0.0008 0.0006  0.0011 Per-act HIV-1 transmission probability, male to female37  
Probability of HIV 
transmission, female to male, 
through peno-vaginal sex 
𝛽𝛽𝑚𝑚 0.0004 0.0001 0.0014 Per-act HIV-1 transmission probability, female to male37 
Multiplicative increase in per 
sex act probability of HIV 
transmission in the presence of 
an STI 
𝛿𝛿 3.7 2 6 Combined study effectiveness estimate across STDs, and 
range spanning individual STD combined study effect 
estimates38 
Average reduction in 
probability HIV transmission on 
ART 
𝜚𝜚 0.92 0.99 0.9 Estimate:39 accounting for heterogeneity in sexual mixing 
and stage of infection, of all studies reviewed in systematic 
comparison.40 
Low and high: min and max of all studies.40 
Average reduction in 
probability HIV transmission to 
males, when male partner has 
been circumcised 
𝜎𝜎𝑚𝑚 0.6 0.66 0.44 Average,41 low and high risk from CI in42. 
Average reduction in 
probability HIV transmission to 
females, when male partner has 
been circumcised 
𝜎𝜎𝑓𝑓 0 0 0.2 Male circumcision; estimates of HIV infection in women.41  
Number of unit time steps 
(duration) spent in PrEP 
programme/ cascade following 
uptake 
h 3 months N/A N/A Frequency of HIV testing (minimum of all regular testing 
requirements) WHO Implementation Tool (2017).43 
Underlying population mortality 
rate per unit time step in 
females 
𝜇𝜇𝑓𝑓 0.003788 0.003571 0.00625 1/ life expectancy at birth, females, divided by 4 (for 3 
month time unit).44 
Underlying population mortality 
rate per unit time step in males 
𝜇𝜇𝑚𝑚  0.003968 0.003571 0.00625 1/ life expectancy at birth, females, divided by 4 (for 3 
month time unit).44 
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Parameter Symbol Estimate Low High  References 
Rate of AIDS deaths per unit 
time step, females  
𝜉𝜉𝑓𝑓 0.018775 0.012108 0.022353 As in,45 from,46 average time from HIV infection to death of 
10.2 years. Multiplied by 4. Inverted and multiplied by (1- 
proportion of females on ART).  
Rate of AIDS deaths per unit 
time step, males  
𝜉𝜉𝑚𝑚 0.018211  0.016985 0.019436 As in,45 from, 46 average time from HIV infection to death of 
10.2 years. Multiplied by 4. Inverted and multiplied by (1- 
proportion of males on ART). 
Table S1: Parameters and data sources used in the parameterisation and fitting of the models. Low and high estimates are 95% confidence intervals from the named 






Model fits to data 
The model fits to HIV prevalence corresponding to each level of initial condom consistency are shown below in 
Figure 1 for the Epidemic Equilibrium scenario, and for the Increasing Epidemic scenario in Figure 2. 






Figure S1: Plots of fits to FSW and male partner population HIV prevalence over time calculated through the dynamic 
model for the Epidemic Equilibrium scenario. The plots are given distinctly for each level of initial condom consistency (in 
2014) simulated, and in each case display the 95% and 50% credible intervals and median of all fits. 
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Figure S2: Plots of fits to FSW and male partner population HIV prevalence over time calculated through the dynamic 
model for the Increasing Epidemic scenario. The plots are given distinctly for each level of initial condom consistency (in 






Model fits for additional analyses 
 
The model fits to HIV prevalence corresponding to each level of initial condom consistency for the structural 
sensitivity analysis are shown below in Figure 1 for the Epidemic Equilibrium scenario, and for the Increasing 
Epidemic scenario in Figure 2. 
Structural Sensitivity Analysis 






Figure S3: Plots of fits to FSW and male partner population HIV prevalence over time calculated through the dynamic 
model for the Epidemic Equilibrium scenario under the structural sensitivity analysis. The plots are given distinctly for 
each level of initial condom consistency (in 2014) simulated, and in each case display the 95% and 50% credible intervals 
and median of all fits. 
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Structural Sensitivity Analysis 






Figure S4: Plots of fits to FSW and male partner population HIV prevalence over time calculated through the dynamic 
model for the Increasing Epidemic scenario under the structural sensitivity analysis. The plots are given distinctly for 
each level of initial condom consistency (in 1994) simulated, and in each case display the 95% and 50% credible intervals 
and median of all fits. 
 
Fully Endemic Scenario 
The model fits to HIV prevalence for the Fully Endemic analysis are the same as those for the Epidemic 
Equilibrium scenario – it is only PrEP that is implemented later in this analysis. 
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Boxplots for additional analyses 
 
The 4x4 boxplots showing 1) the lowest level of condom consistency, and 2) the percentage reduction in 
condom consistency, tolerated following the introduction of PrEP for each of the scenarios evaluated are set out 
as follows: 
- Epidemic Equilibria scenario in Figure S5 and Figure S6 respectively; 
- Increasing Epidemic scenario in Figure S7 and Figure S8 respectively; 
- Structural sensitivity analysis - Epidemic Equilibrium scenario in Figure S9 and Figure S10 respectively; 
- Structural sensitivity analysis – Increasing Epidemic scenario in Figure S11 and Figure S12 respectively; 
and 




Figure S5: Boxplots comparing the lowest level of condom consistency tolerated on PrEP (for HIV risk not to increase) predicted through the static and dynamic models – PrEP introduced at 
HIV Epidemic Equilibrium. The results are shown distinctly for initial condom consistencies (at point of introduction of PrEP) of 10%, 30%, 50% and 70%, and simulated for levels of achieved 
PrEP use-effectiveness at HIV risk reduction of 25%, 45%, 65% and 85%. In the case of the static model, the predicted lowest levels of condom consistency tolerated on PrEP are point estimates. 
In the case of the dynamic model, the predicted lowest levels of condom consistency tolerated on PrEP are given after 3 months, 1 year, 2 years, 5 years, 10 years and 20 years on PrEP. The 
boxplots depict uncertainty in the lowest levels of condom consistency tolerated, with the black line representing the median of all fits, the coloured section the interquartile range and the 




Figure S6: Boxplots comparing the percentage reduction in condom consistency tolerated on PrEP (for HIV risk not to increase) predicted through the static and dynamic models – PrEP 
introduced at HIV Epidemic Equilibrium. The results are shown distinctly for initial condom consistencies (at point of introduction of PrEP) of 10%, 30%, 50% and 70%, and simulated for levels 
of achieved PrEP use-effectiveness at HIV risk reduction of 25%, 45%, 65% and 85%. In the case of the static model, the predicted percentage reductions in condom consistency tolerated on 
PrEP are point estimates. In the case of the dynamic model, the predicted percentage reductions in condom consistency tolerated on PrEP are given after 3 months, 1 year, 2 years, 5 years, 10 
years and 20 years on PrEP. The boxplots depict uncertainty in the percentage reduction in condom consistency tolerated, with the black line representing the median of all fits, the coloured 




Figure S7: Boxplots comparing the lowest level of condom consistency tolerated on PrEP (for HIV risk not to increase) predicted through the static and dynamic models – PrEP introduced 
with Increasing Epidemic. The results are shown distinctly for initial condom consistencies (at point of introduction of PrEP) of 10%, 30%, 50% and 70%, and simulated for levels of achieved 
PrEP use-effectiveness at HIV risk reduction of 25%, 45%, 65% and 85%. In the case of the static model, the lowest levels of condom consistency tolerated on PrEP are point estimates. In the 
case of the dynamic model, the lowest levels of condom consistency tolerated on PrEP are given after 3 months, 1 year, 2 years, 5 years, 10 years and 20 years on PrEP. The boxplots depict 
uncertainty in the lowest levels of condom consistency tolerated, with the black line representing the median of all fits, the coloured section the interquartile range and the whiskers the 




Figure S8: Boxplots comparing the percentage reduction in condom consistency tolerated on PrEP (for HIV risk not to increase) predicted through the static and dynamic models – PrEP 
introduced with Increasing Epidemic. The results are shown distinctly for initial condom consistencies (at point of introduction of PrEP) of 10%, 30%, 50% and 70%, and simulated for levels of 
achieved PrEP use-effectiveness at HIV risk reduction of 25%, 45%, 65% and 85%. In the case of the static model, the predicted percentage reductions in condom consistency tolerated on PrEP 
are point estimates. In the case of the dynamic model, the predicted percentage reductions in condom consistency tolerated on PrEP are given after 3 months, 1 year, 2 years, 5 years, 10 years 
and 20 years on PrEP. The boxplots depict uncertainty in the percentage reduction in condom consistency tolerated, with the black line representing the median of all fits, the coloured section 
the interquartile range and the whiskers the maximum and minimum values. 
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Structural sensitivity analysis: Epidemic Equilibrium Scenario 
 
Figure S9: Boxplots comparing the lowest level of condom consistency tolerated on PrEP (for HIV risk not to increase) predicted through the static and dynamic models – PrEP introduced at 
HIV Epidemic Equilibrium under the structural sensitivity analysis. The results are shown distinctly for initial condom consistencies (at point of introduction of PrEP) of 10%, 30%, 50% and 
70%, and simulated for levels of achieved PrEP use-effectiveness at HIV risk reduction of 25%, 45%, 65% and 85%. In the case of the static model, the lowest levels of condom consistency 
tolerated on PrEP are point estimates. In the case of the dynamic model, the lowest level of condom consistency tolerated on PrEP are given after 3 months, 1 year, 2 years, 5 years, 10 years 
and 20 years on PrEP. The boxplots depict uncertainty in the lowest level of condom consistency tolerated, with the black line representing the median of all fits, the coloured section the 
interquartile range and the whiskers the maximum and minimum values. 
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Figure S10: Boxplots comparing the percentage reduction in condom consistency tolerated on PrEP (for HIV risk not to increase) predicted through the static and dynamic models – PrEP 
introduced at HIV Epidemic Equilibrium under the structural sensitivity analysis. The results are shown distinctly for initial condom consistencies (at point of introduction of PrEP) of 10%, 
30%, 50% and 70%, and simulated for levels of achieved PrEP use-effectiveness at HIV risk reduction of 25%, 45%, 65% and 85%. In the case of the static model, the predicted percentage 
reductions in condom consistency tolerated on PrEP are point estimates. In the case of the dynamic model, the predicted percentage reductions in condom consistency tolerated on PrEP are 
given after 3 months, 1 year, 2 years, 5 years, 10 years and 20 years on PrEP. The boxplots depict uncertainty in the percentage reduction in condom consistency tolerated, with the black line 
representing the median of all fits, the coloured section the interquartile range and the whiskers the maximum and minimum values. 
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Structural sensitivity analysis: Increasing Epidemic Scenario 
 
Figure S11: Boxplots comparing the lowest level of condom consistency tolerated on PrEP (for HIV risk not to increase) predicted through the static and dynamic models – PrEP introduced 
with Increasing Epidemic under the structural sensitivity analysis. The results are shown distinctly for initial condom consistencies (at point of introduction of PrEP) of 10%, 30%, 50% and 
70%, and simulated for levels of achieved PrEP use-effectiveness at HIV risk reduction of 25%, 45%, 65% and 85%. In the case of the static model, the lowest levels of condom consistency 
tolerated on PrEP are point estimates. In the case of the dynamic model, the lowest levels of condom consistency tolerated on PrEP are given after 3 months, 1 year, 2 years, 5 years, 10 years 
and 20 years on PrEP. The boxplots depict uncertainty in the lowest level of condom consistency tolerated, with the black line representing the median of all fits, the coloured section the 




Figure S12: Boxplots comparing the percentage reduction in condom consistency tolerated on PrEP (for HIV risk not to increase) predicted through the static and dynamic models – PrEP 
introduced with Increasing Epidemic under the structural sensitivity analysis. The results are shown distinctly for initial condom consistencies (at point of introduction of PrEP) of 10%, 30%, 
50% and 70%, and simulated for levels of achieved PrEP use-effectiveness at HIV risk reduction of 25%, 45%, 65% and 85%. In the case of the static model, the predicted percentage reductions 
in condom consistency tolerated on PrEP are point estimates. In the case of the dynamic model, the predicted percentage reductions in condom consistency tolerated on PrEP are given after 3 
months, 1 year, 2 years, 5 years, 10 years and 20 years on PrEP. The boxplots depict uncertainty in the percentage reduction in condom consistency tolerated, with the black line representing 
the median of all fits, the coloured section the interquartile range and the whiskers the maximum and minimum values.
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Fully Endemic Scenario 
 
Figure S13: Boxplots comparing the lowest level of condom consistency tolerated on PrEP (for HIV risk not to increase) predicted through the static and dynamic models – PrEP introduced 
with the Fully Endemic scenario. The results are shown distinctly for initial condom consistencies (at point of introduction of PrEP) of 10%, 30%, 50% and 70%, and simulated for levels of 
achieved PrEP use-effectiveness at HIV risk reduction of 25%, 45%, 65% and 85%. In the case of the static model, the lowest levels of condom consistency tolerated on PrEP are point estimates. 
In the case of the dynamic model, the lowest levels of condom consistency tolerated on PrEP are given after 3 months, 1 year, 2 years, 5 years, 10 years and 20 years on PrEP. The boxplots 
depict uncertainty in the lowest levels of condom consistency tolerated, with the black line representing the median of all fits, the coloured section the interquartile range and the whiskers the 




Figure S14: Boxplots comparing the percentage reduction in condom consistency tolerated on PrEP (for HIV risk not to increase) predicted through the static and dynamic models – PrEP 
introduced with the Fully Endemic scenario. The results are shown distinctly for initial condom consistencies (at point of introduction of PrEP) of 10%, 30%, 50% and 70%, and simulated for 
levels of achieved PrEP use-effectiveness at HIV risk reduction of 25%, 45%, 65% and 85%. In the case of the static model, the predicted percentage reductions in condom consistency tolerated 
on PrEP are point estimates. In the case of the dynamic model, the predicted percentage reductions in condom consistency tolerated on PrEP are given after 3 months, 1 year, 2 years, 5 years, 
10 years and 20 years on PrEP. The boxplots depict uncertainty in the percentage reduction in condom consistency tolerated, with the black line representing the median of all fits, the coloured 
section the interquartile range and the whiskers the maximum and minimum values.
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Percentage Reduction in Condom Consistency Tolerated: Tables of percentage change between 
static and dynamic model’s outcomes 
 
The percentage change between the median and 95% credible interval (CrI) of the static and dynamic models’ 
predictions of the percentage change in condom consistency tolerated over the time horizon for both the 
Epidemic Equilibrium and Increasing Epidemic scenarios are shown in Tables S2a and S2b respectively. 
 
Epidemic Equilibrium Scenario 
 
 
Table S2a: Epidemic Equilibrium Scenario: Percentage change between the static and dynamic models’ 
prediction of the percentage change in condom consistency tolerated, when the dynamic model is run over a 
time horizon of 3 months to 20 years. 
 
 
Increasing Epidemic Scenario 
 
Table S2b: Increasing Epidemic Scenario: Percentage change between the static and dynamic models’ 
prediction of the percentage change in condom consistency tolerated, when the dynamic model is run over a 
time horizon of 3 months to 20 years.  
 
Tables S2a and S2b respectively show for the scenarios where PrEP is introduced at Epidemic Equilibrium and 
where PrEP is introduced with Increasing Epidemic the percentage change between the static and dynamic 
models’ prediction of the percentage change in condom consistency tolerated, when the dynamic model is run 
over a time horizon of 3 months to 20 years. The percentage change values stated outside the brackets are the 
percentage change between the median values predicted by the static and dynamic models, and the values in the 
left and right of the bracket are the percentage change between the lower and upper 95% credible intervals 
predicted by the static and dynamic models respectively.  
 






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0.8 % , 0 % )
0.1 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.85 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0.1 % , 0 % )
0.3 0.25 -1.9 %  ( -0.7 % , -1.4 % ) -0.1 %  ( 2.8 % , -0.8 % ) 2 %  ( 9.2 % , -3.3 % ) 4 %  ( 23.5 % , -10.8 % ) 3.6 %  ( 100 % , -19.2 % ) 4 %  ( 67.2 % , -19.2 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 29.2 % , 0 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 -2.1 %  ( -2 % , -1.5 % ) -2.1 %  ( 1.7 % , -1.5 % ) -2.4 %  ( 10.7 % , -2.7 % ) -2.9 %  ( 32 % , -15.5 % ) -4.4 %  ( 100 % , -28.3 % ) -5.9 %  ( 92 % , -38.9 % )
0.5 0.45 -0.8 %  ( -1.2 % , -0.8 % ) 3.7 %  ( 3.8 % , 5.2 % ) 7.2 %  ( 10.5 % , 8.5 % ) 13.3 %  ( 26.3 % , 13.1 % ) 17.9 %  ( 100 % , 11.8 % ) 21.9 %  ( 62.6 % , 11 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 32.4 % , 0 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.7 0.25 -2.7 %  ( -1.9 % , -2.3 % ) -4.3 %  ( 1.9 % , -3.7 % ) -8.7 %  ( 7.5 % , -9.3 % ) -13.6 %  ( 27.5 % , -24.7 % ) -19 %  ( 100 % , -40.5 % ) -20.1 %  ( 100 % , -56.7 % )
0.7 0.45 -1.2 %  ( -1.1 % , -1.4 % ) 2.3 %  ( 3.2 % , 2.4 % ) 5.1 %  ( 8.4 % , 5.4 % ) 7.6 %  ( 22.2 % , 5.8 % ) 11.1 %  ( 100 % , 4.8 % ) 14.1 %  ( 66.8 % , 1.2 % )
0.7 0.65 -0.7 %  ( -0.5 % , 0 % ) 5.9 %  ( 5.8 % , 1.2 % ) 12.1 %  ( 11.8 % , 8.1 % ) 20.5 %  ( 24.8 % , 15.9 % ) 26.1 %  ( 100 % , 20.5 % ) 30.6 %  ( 53.5 % , 21 % )
0.7 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0.7 % , 0 % )






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 4.3 % , 0 % ) 48.7 %  ( 87.5 % , 5.3 % ) 100 %  ( 100 % , 100 % ) 100 %  ( 100 % , 100 % ) 100 %  ( 100 % , 20.1 % )
0.1 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 4.5 %  ( 69.6 % , 0 % ) 87 %  ( 100 % , 0 % ) 18.4 %  ( 100 % , 0 % )
0.1 0.65 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.85 0.1 %  ( 0.2 % , 0 % ) 0.1 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % )
0.3 0.25 8.8 %  ( 9.3 % , 9 % ) 43.8 %  ( 50.6 % , 40.8 % ) 73.1 %  ( 89.8 % , 62.2 % ) 100 %  ( 100 % , 93.3 % ) 100 %  ( 100 % , 100 % ) 100 %  ( 100 % , 67.7 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 9.5 % , 0 % ) 22.2 %  ( 41.1 % , 2.5 % ) 66.8 %  ( 89.2 % , 44 % ) 90.1 %  ( 100 % , 61.2 % ) 71.1 %  ( 100 % , 28.5 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 21.1 % , 0 % ) 22.8 %  ( 63.1 % , 0 % ) 5.7 %  ( 66 % , 0 % )
0.3 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 7.1 %  ( 7.1 % , 7.8 % ) 37.2 %  ( 40.7 % , 34.4 % ) 63.1 %  ( 76.8 % , 55 % ) 100 %  ( 100 % , 82.9 % ) 100 %  ( 100 % , 90.5 % ) 100 %  ( 100 % , 50.3 % )
0.5 0.45 4.1 %  ( 3.5 % , 4.4 % ) 27.8 %  ( 27.8 % , 27.6 % ) 45.9 %  ( 48.5 % , 44.2 % ) 72.5 %  ( 83.2 % , 65.2 % ) 86.9 %  ( 100 % , 73.5 % ) 75.4 %  ( 100 % , 54.6 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 6.7 %  ( 20.4 % , 0 % ) 38.4 %  ( 52.4 % , 21.3 % ) 54.7 %  ( 72.7 % , 35.2 % ) 46.8 %  ( 76.1 % , 15.8 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 4.7 % , 0 % )
0.7 0.25 5.9 %  ( 4.5 % , 5.6 % ) 32.4 %  ( 31.2 % , 28.7 % ) 54.3 %  ( 61.1 % , 47.2 % ) 92.6 %  ( 100 % , 76.4 % ) 100 %  ( 100 % , 90.3 % ) 91 %  ( 100 % , 47.2 % )
0.7 0.45 2.8 %  ( 2.2 % , 3.1 % ) 23.9 %  ( 22.6 % , 22.7 % ) 40.8 %  ( 39.9 % , 38.6 % ) 66.3 %  ( 73.6 % , 60.3 % ) 80 %  ( 100 % , 70.5 % ) 71.6 %  ( 100 % , 52.4 % )
0.7 0.65 2.1 %  ( 1.6 % , 0 % ) 23.7 %  ( 21.6 % , 16.4 % ) 37.5 %  ( 36.8 % , 31.9 % ) 57.9 %  ( 59.8 % , 53 % ) 68.5 %  ( 75.1 % , 61.9 % ) 63.8 %  ( 81.7 % , 52 % )




Additional analyses – Structural sensitivity analysis 
The percentage change between the median and 95% credible interval (CrI) of the static and dynamic models’ 
predictions of the percentage change in condom consistency tolerated over the time horizon for both the 
Epidemic Equilibrium and Increasing Epidemic scenarios for the structural sensitivity analysis are shown in 
Tables S3a and S3b respectively. 
 
Structural Sensitivity Analysis 
Epidemic Equilibrium Scenario 
 
 
Table S3a: Structural sensitivity analysis: Epidemic Equilibrium Scenario: Percentage change between the 
static and dynamic models’ prediction of the percentage change in condom consistency tolerated, when the 
dynamic model is run over a time horizon of 3 months to 20 years. 
 
 
Structural Sensitivity Analysis 
Increasing Epidemic Scenario 
 
Table S3b: Structural sensitivity analysis: Increasing Epidemic Scenario: Percentage change between the 
static and dynamic models’ prediction of the percentage change in condom consistency tolerated, when the 
dynamic model is run over a time horizon of 3 months to 20 years. 
 
Tables S3a and S3b respectively show, for the scenarios where PrEP is introduced at Epidemic Equilibrium 
and where PrEP is introduced with Increasing Epidemic under the structural sensitivity analysis, the 
percentage change between the static and dynamic models’ prediction of the percentage change in condom 
consistency tolerated, when the dynamic model is run over a time horizon of 3 months to 20 years. The 
percentage change values stated outside the brackets are the percentage change between the median values 
predicted by the static and dynamic models, and the values in the left and right of the bracket are the percentage 
change between the lower and upper 95% credible intervals predicted by the static and dynamic models 
respectively.  






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 42.3 % , 0 % )
0.1 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.85 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0.1 % , 0 % )
0.3 0.25 0.8 %  ( 0.9 % , 0 % ) 10.9 %  ( 11.6 % , 4.1 % ) 20.1 %  ( 23.7 % , 11.2 % ) 34.7 %  ( 45.3 % , 22.5 % ) 44.5 %  ( 100 % , 27.2 % ) 49.9 %  ( 82.6 % , 26 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 13.4 % , 0 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 0.4 %  ( 0.5 % , 0.6 % ) 8.8 %  ( 10.7 % , 7.6 % ) 16.8 %  ( 22.7 % , 13.9 % ) 30.1 %  ( 49.8 % , 23.5 % ) 39.6 %  ( 100 % , 27.4 % ) 46.2 %  ( 100 % , 28.2 % )
0.5 0.45 0 %  ( 0 % , 0 % ) 0.6 %  ( 10.1 % , 0 % ) 10.5 %  ( 20 % , 0.4 % ) 25.1 %  ( 37.9 % , 14.7 % ) 35.1 %  ( 100 % , 23.5 % ) 41.8 %  ( 70.8 % , 29.1 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 7.1 % , 0 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.7 0.25 -0.9 %  ( 0 % , 0.4 % ) 5.3 %  ( 8 % , 5 % ) 11.9 %  ( 20.1 % , 8.8 % ) 22 %  ( 47.7 % , 13 % ) 30.4 %  ( 100 % , 12.6 % ) 37.4 %  ( 100 % , 10.3 % )
0.7 0.45 -0.4 %  ( 0 % , 0.6 % ) 7.7 %  ( 8.6 % , 8.6 % ) 15.3 %  ( 17.4 % , 15.6 % ) 28.4 %  ( 36.6 % , 25 % ) 36.8 %  ( 100 % , 30.9 % ) 43.8 %  ( 78.7 % , 34.5 % )
0.7 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 2.3 % , 0 % ) 0.6 %  ( 13 % , 0 % ) 17.4 %  ( 29.8 % , 4.6 % ) 29 %  ( 100 % , 15.2 % ) 36.6 %  ( 57.4 % , 22.1 % )
0.7 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 9.2 %  ( 51.6 % , 0 % ) 100 %  ( 100 % , 93.9 % ) 100 %  ( 100 % , 100 % ) 100 %  ( 100 % , 100 % )
0.1 0.45 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0 % , 0 % ) 90.7 %  ( 100 % , 0 % ) 100 %  ( 100 % , 51 % )
0.1 0.65 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 32.2 % , 0 % )
0.1 0.85 0.1 %  ( 0.2 % , 0 % ) 0.1 %  ( 0.2 % , 0 % ) 0.1 %  ( 0.2 % , 0 % ) 0.1 %  ( 0.2 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % )
0.3 0.25 9.1 %  ( 9.9 % , 3.8 % ) 43.3 %  ( 48.7 % , 35.5 % ) 71.6 %  ( 81.8 % , 58.7 % ) 100 %  ( 100 % , 95.2 % ) 100 %  ( 100 % , 100 % ) 100 %  ( 100 % , 100 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 3.4 % , 0 % ) 50.4 %  ( 68.9 % , 25.6 % ) 91.8 %  ( 100 % , 63.5 % ) 100 %  ( 100 % , 87.9 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 27.8 % , 0 % ) 47.1 %  ( 90.6 % , 2.2 % )
0.3 0.85 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 7.1 %  ( 8 % , 7.1 % ) 37.3 %  ( 42 % , 34.5 % ) 64.2 %  ( 73.8 % , 55.4 % ) 100 %  ( 100 % , 86.3 % ) 100 %  ( 100 % , 100 % ) 100 %  ( 100 % , 100 % )
0.5 0.45 0 %  ( 3.1 % , 0 % ) 21.1 %  ( 30 % , 12.7 % ) 41.7 %  ( 50.7 % , 32.8 % ) 71.8 %  ( 82.6 % , 60.1 % ) 92.7 %  ( 100 % , 76.3 % ) 100 %  ( 100 % , 89 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 13.6 %  ( 30.7 % , 0 % ) 46.5 %  ( 64.4 % , 25.3 % ) 72.3 %  ( 94.3 % , 46.2 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 6.1 % , 0 % )
0.7 0.25 5.7 %  ( 6.1 % , 6.2 % ) 30 %  ( 32.8 % , 26.3 % ) 53 %  ( 60.6 % , 44.4 % ) 92.6 %  ( 100 % , 71.8 % ) 100 %  ( 100 % , 91.9 % ) 100 %  ( 100 % , 100 % )
0.7 0.45 3 %  ( 3.3 % , 3.1 % ) 23.8 %  ( 24.9 % , 23.1 % ) 40.8 %  ( 43.1 % , 38 % ) 66.3 %  ( 73.2 % , 58 % ) 85.8 %  ( 98.6 % , 71.8 % ) 100 %  ( 100 % , 83.6 % )
0.7 0.65 0 %  ( 0 % , 0 % ) 4.4 %  ( 18 % , 0 % ) 24 %  ( 35.6 % , 13.2 % ) 50.3 %  ( 60 % , 37.2 % ) 67.6 %  ( 77.4 % , 52.2 % ) 82.7 %  ( 95.9 % , 64.3 % )





Additional analyses - Fully Endemic scenario 
The percentage change between the median and 95% credible interval (CrI) of the static and dynamic models’ 
predictions of the percentage change in condom consistency tolerated over the time horizon for the additional 
scenario Fully Endemic (PrEP introduced in 2030) is shown in Table S4. 
 
Fully Endemic Scenario 
 
Table S4: Percentage change between the static and dynamic models’ prediction of the percentage change in 
condom consistency tolerated, when the dynamic model is run over a time horizon of 3 months to 20 years, 
under the Fully Endemic scenario. The percentage change values stated outside the brackets are the 
percentage change between the median values predicted by the static and dynamic models, and the values in the 
left and right of the bracket are the percentage change between the lower and upper 95% credible intervals 
predicted by the static and dynamic models respectively.  
  






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.65 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.85 0 %  ( 0.1 % , 0 % ) 0.1 %  ( 0.1 % , 0 % ) 0 %  ( 0.2 % , 0 % ) 0 %  ( 0.1 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0.1 % , 0 % )
0.3 0.25 -0.9 %  ( -1 % , -0.6 % ) 3.5 %  ( 4.2 % , 4.9 % ) 8.2 %  ( 10.3 % , 7.3 % ) 15.8 %  ( 24.6 % , 9.4 % ) 22.1 %  ( 100 % , 8.9 % ) 26.8 %  ( 53.3 % , 7.9 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 2.1 %  ( 23 % , 0 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 -0.6 %  ( -1 % , -0.7 % ) 4.1 %  ( 4 % , 3 % ) 8.2 %  ( 12 % , 5.7 % ) 15.7 %  ( 35.1 % , 4.7 % ) 20.4 %  ( 100 % , 1.2 % ) 25.4 %  ( 81.6 % , 0.5 % )
0.5 0.45 -0.4 %  ( -0.4 % , -0.5 % ) 7.2 %  ( 6.7 % , 6.8 % ) 13.8 %  ( 13.6 % , 13.4 % ) 24.4 %  ( 27 % , 22.1 % ) 31.6 %  ( 100 % , 25.5 % ) 37.8 %  ( 57.4 % , 28.3 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 3.6 % , 0 % ) 0.3 %  ( 100 % , 0 % ) 9.7 %  ( 28.8 % , 0 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
0.7 0.25 -1.1 %  ( -1.3 % , 0 % ) 2.1 %  ( 2.5 % , 2.3 % ) 6.3 %  ( 13.2 % , 2.3 % ) 11.1 %  ( 44.7 % , 0 % ) 15.8 %  ( 100 % , -6.4 % ) 18.9 %  ( 100 % , -10 % )
0.7 0.45 -0.9 %  ( -0.8 % , -0.2 % ) 5.9 %  ( 5.4 % , 6.7 % ) 12.2 %  ( 11.4 % , 12.1 % ) 22.4 %  ( 28.5 % , 19 % ) 29.3 %  ( 100 % , 23.5 % ) 35.8 %  ( 63.7 % , 24.4 % )
0.7 0.65 -0.5 %  ( -0.5 % , 0 % ) 9.2 %  ( 9.4 % , 1.3 % ) 17.9 %  ( 16.9 % , 10.5 % ) 29.9 %  ( 29.5 % , 22.8 % ) 37.9 %  ( 100 % , 29.3 % ) 43.6 %  ( 50.5 % , 34.7 % )
0.7 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 12.6 % , 0 % )
28 
 
Lowest Level of Condom Consistency Tolerated: Tables of absolute difference between static 
and dynamic model’s outcomes 
 
The absolute difference between the median and 95% credible interval (CrI) of the static and dynamic models’ 
predictions of the lowest level of condom consistency tolerated over the time horizon for both the Epidemic 
Equilibrium and Increasing Epidemic scenarios are shown in Tables S5a and S5b respectively. 
 




Table S5a: Epidemic Equilibrium Scenario: Absolute difference between the static and dynamic models’ 
prediction of the lowest level of condom consistency tolerated, when the dynamic model is run over a time 
horizon of 3 months to 20 years. 
 
 
Increasing Epidemic Scenario 
 
 
Table S5b: Increasing Epidemic Scenario: Absolute difference between the static and dynamic models’ 
prediction of the lowest level of condom consistency tolerated, when the dynamic model is run over a time 
horizon of 3 months to 20 years.  
 
Tables S5a and S5b respectively show for the scenarios where PrEP is introduced at Epidemic Equilibrium and 
where PrEP is introduced with Increasing Epidemic the absolute difference between the static and dynamic 
models’ prediction of the lowest level of condom consistency tolerated, when the dynamic model is run over a 
time horizon of 3 months to 20 years. The values stated outside the brackets are the absolute difference between 
the median values predicted by the static and dynamic models, and the values in the left and right of the bracket 
are the absolute difference between the lower and upper 95% credible intervals predicted by the static and 
dynamic models respectively.  






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -0.1 % )
0.1 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.25 0.4 %  ( 0.3 % , 0.1 % ) 0 %  ( 0.2 % , -0.5 % ) -0.5 %  ( 0.8 % , -1.7 % ) -0.9 %  ( 2.7 % , -4.3 % ) -0.8 %  ( 4.8 % , -7.5 % ) -0.9 %  ( 4.8 % , -12.3 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -3.1 % ) 0 %  ( 0 % , -8.8 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 0.3 %  ( 0.3 % , 0.3 % ) 0.3 %  ( 0.3 % , -0.3 % ) 0.3 %  ( 0.6 % , -1.6 % ) 0.5 %  ( 3.2 % , -4.8 % ) 0.7 %  ( 5.7 % , -8.5 % ) 1 %  ( 7.9 % , -13.8 % )
0.5 0.45 0.3 %  ( 0.3 % , 0.4 % ) -1.5 %  ( -2.6 % , -1.3 % ) -2.8 %  ( -4.2 % , -3.6 % ) -5.2 %  ( -6.3 % , -9 % ) -7 %  ( -5.7 % , -14.1 % ) -8.5 %  ( -5.4 % , -21.5 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -6.5 % ) 0 %  ( 0 % , -16.2 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.7 0.25 0.3 %  ( 0.4 % , 0.2 % ) 0.5 %  ( 0.6 % , -0.2 % ) 1.1 %  ( 1.5 % , -0.8 % ) 1.7 %  ( 3.8 % , -3.1 % ) 2.4 %  ( 6.2 % , -6.9 % ) 2.6 %  ( 8.6 % , -12.8 % )
0.7 0.45 0.4 %  ( 0.5 % , 0.3 % ) -0.7 %  ( -0.9 % , -0.8 % ) -1.5 %  ( -1.9 % , -2.2 % ) -2.3 %  ( -2 % , -5.7 % ) -3.4 %  ( -1.7 % , -10.3 % ) -4.3 %  ( -0.4 % , -17.3 % )
0.7 0.65 0.4 %  ( 0 % , 0.2 % ) -3.7 %  ( -0.8 % , -3.1 % ) -7.5 %  ( -5.7 % , -6.3 % ) -12.8 %  ( -11.1 % , -13.3 % ) -16.4 %  ( -14.4 % , -19.2 % ) -19.2 %  ( -14.7 % , -28.5 % )
0.7 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -0.5 % )






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -0.4 % ) -4.9 %  ( -0.5 % , -8.8 % ) -16.6 %  ( -10.5 % , -22.4 % ) -22.4 %  ( -14.4 % , -30.6 % ) -15.2 %  ( -2 % , -28.8 % )
0.1 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) -0.4 %  ( 0 % , -7 % ) -8.7 %  ( 0 % , -17.4 % ) -1.8 %  ( 0 % , -15.3 % )
0.1 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.25 -1.9 %  ( -2.3 % , -1.6 % ) -9.1 %  ( -10.1 % , -8.9 % ) -15.2 %  ( -15.3 % , -15.9 % ) -24.9 %  ( -22.9 % , -27.5 % ) -30.1 %  ( -25.7 % , -35.3 % ) -24.2 %  ( -16.7 % , -35.8 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -2.9 % ) -6.7 %  ( -0.8 % , -12.3 % ) -20 %  ( -13.2 % , -26.8 % ) -27 %  ( -18.4 % , -36.3 % ) -21.3 %  ( -8.5 % , -37.3 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -6.3 % ) -6.9 %  ( 0 % , -18.9 % ) -1.7 %  ( 0 % , -19.8 % )
0.3 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 -1.2 %  ( -1.6 % , -1 % ) -6.4 %  ( -6.8 % , -6 % ) -10.7 %  ( -10.9 % , -11.3 % ) -18.2 %  ( -16.5 % , -20.4 % ) -22.1 %  ( -18 % , -26.8 % ) -17.2 %  ( -10 % , -26.9 % )
0.5 0.45 -1.5 %  ( -2.1 % , -1.2 % ) -10.9 %  ( -12.9 % , -9.5 % ) -18 %  ( -20.7 % , -16.5 % ) -28.4 %  ( -30.5 % , -28.3 % ) -34.1 %  ( -34.4 % , -36.2 % ) -29.6 %  ( -25.6 % , -37.3 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) -3.3 %  ( 0 % , -10.2 % ) -19.2 %  ( -10.6 % , -26.2 % ) -27.4 %  ( -17.6 % , -36.4 % ) -23.4 %  ( -7.9 % , -38 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -2.4 % )
0.7 0.25 -0.8 %  ( -0.8 % , -0.5 % ) -4.3 %  ( -4.3 % , -3.4 % ) -7.2 %  ( -7.2 % , -6.7 % ) -12.2 %  ( -11.5 % , -13.3 % ) -15.3 %  ( -13.6 % , -18.1 % ) -12 %  ( -7.1 % , -19.6 % )
0.7 0.45 -0.9 %  ( -1.1 % , -0.6 % ) -7.3 %  ( -8.1 % , -5.7 % ) -12.4 %  ( -13.8 % , -10.1 % ) -20.2 %  ( -21.6 % , -18.7 % ) -24.4 %  ( -25.2 % , -25.4 % ) -21.8 %  ( -18.8 % , -27.2 % )
0.7 0.65 -1.3 %  ( 0 % , -0.9 % ) -14.8 %  ( -11.5 % , -11.2 % ) -23.5 %  ( -22.3 % , -19.3 % ) -36.3 %  ( -37.1 % , -31.3 % ) -43 %  ( -43.3 % , -39.3 % ) -40.1 %  ( -36.4 % , -42.7 % )
0.7 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) -3.9 %  ( 0 % , -14.7 % ) -15.8 %  ( -1.8 % , -27.8 % ) -10.8 %  ( 0 % , -33 % )
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Additional analyses – Structural sensitivity analysis 
The absolute difference between the median and 95% credible interval (CrI) of the static and dynamic models’ 
predictions of the lowest level of condom consistency tolerated over the time horizon for both the Epidemic 
Equilibrium and Increasing Epidemic scenarios for the structural sensitivity analysis are shown in Tables S6a 
and S6b respectively. 
 
Structural Sensitivity Analysis 




Table S6a: Structural sensitivity analysis: Epidemic Equilibrium Scenario: Absolute difference between the 
static and dynamic models’ prediction of the lowest level of condom consistency tolerated, when the dynamic 
model is run over a time horizon of 3 months to 20 years. 
 
 
Structural Sensitivity Analysis 
Increasing Epidemic Scenario 
 
Table 6b: Structural sensitivity analysis: Increasing Epidemic Scenario: Absolute difference between the 
static and dynamic models’ prediction of the lowest level of condom consistency tolerated, when the dynamic 
model is run over a time horizon of 3 months to 20 years. 
 
Tables S6a and S6b respectively show, for the scenarios where PrEP is introduced at Epidemic Equilibrium 
and where PrEP is introduced with Increasing Epidemic under the structural sensitivity analysis, the absolute 
difference between the static and dynamic models’ prediction of the lowest level of condom consistency 
tolerated, when the dynamic model is run over a time horizon of 3 months to 20 years. The values stated outside 
the brackets are the absolute difference between the median values predicted by the static and dynamic models, 
and the values in the left and right of the bracket are the absolute difference between the lower and upper 95% 
credible intervals predicted by the static and dynamic models respectively.  
 






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -4.2 % )
0.1 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.25 -0.2 %  ( 0 % , -0.3 % ) -3.2 %  ( -1.2 % , -3.2 % ) -5.9 %  ( -3.4 % , -6.5 % ) -10.2 %  ( -6.8 % , -12.3 % ) -13.1 %  ( -8.2 % , -17.4 % ) -14.7 %  ( -7.8 % , -22.5 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -4 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 -0.1 %  ( -0.1 % , -0.1 % ) -2 %  ( -1.8 % , -2.2 % ) -3.8 %  ( -3.4 % , -4.7 % ) -6.8 %  ( -5.8 % , -10.2 % ) -9 %  ( -6.8 % , -15.8 % ) -10.5 %  ( -7 % , -22.3 % )
0.5 0.45 0 %  ( 0 % , 0 % ) -0.3 %  ( 0 % , -5 % ) -5.2 %  ( -0.2 % , -10 % ) -12.5 %  ( -7.4 % , -18.9 % ) -17.5 %  ( -11.8 % , -27.7 % ) -20.9 %  ( -14.5 % , -35.4 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -3.5 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.7 0.25 0.1 %  ( -0.1 % , 0 % ) -0.9 %  ( -0.9 % , -1.1 % ) -1.9 %  ( -1.7 % , -2.7 % ) -3.5 %  ( -2.4 % , -6.6 % ) -4.8 %  ( -2.4 % , -12.6 % ) -6 %  ( -1.9 % , -19.3 % )
0.7 0.45 0.1 %  ( -0.3 % , 0 % ) -3 %  ( -3.9 % , -2.9 % ) -6 %  ( -7 % , -5.9 % ) -11.1 %  ( -11.2 % , -12.5 % ) -14.4 %  ( -13.9 % , -18.9 % ) -17.1 %  ( -15.5 % , -26.9 % )
0.7 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -1.6 % ) -0.4 %  ( 0 % , -9.1 % ) -12.2 %  ( -3.2 % , -20.9 % ) -20.3 %  ( -10.6 % , -31.4 % ) -25.6 %  ( -15.4 % , -40.2 % )
0.7 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) -0.9 %  ( 0 % , -5.2 % ) -17 %  ( -9.4 % , -21.5 % ) -28 %  ( -18.2 % , -33.9 % ) -36 %  ( -23.5 % , -44.4 % )
0.1 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) -9.1 %  ( 0 % , -15.8 % ) -20.7 %  ( -5.1 % , -29.5 % )
0.1 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -3.2 % )
0.1 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.25 -2.7 %  ( -1.1 % , -2.7 % ) -12.7 %  ( -10.7 % , -13.2 % ) -21 %  ( -17.6 % , -22.3 % ) -33.4 %  ( -28.6 % , -36 % ) -42.4 %  ( -35.9 % , -47.2 % ) -49.7 %  ( -41 % , -57 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -1 % ) -15.1 %  ( -7.7 % , -20.7 % ) -27.5 %  ( -19 % , -35 % ) -37.4 %  ( -26.4 % , -48.2 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -8.4 % ) -14.1 %  ( -0.7 % , -27.2 % )
0.3 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 -1.6 %  ( -1.7 % , -1.6 % ) -8.4 %  ( -8.5 % , -8.7 % ) -14.4 %  ( -13.7 % , -15.2 % ) -24.2 %  ( -21.4 % , -26.3 % ) -31.3 %  ( -26.6 % , -34.6 % ) -37.9 %  ( -30.8 % , -42.9 % )
0.5 0.45 0 %  ( 0 % , -1.5 % ) -10.6 %  ( -6.4 % , -15 % ) -20.8 %  ( -16.4 % , -25.4 % ) -35.9 %  ( -30 % , -41.3 % ) -46.4 %  ( -38.2 % , -53 % ) -55.4 %  ( -44.5 % , -63.5 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) -6.8 %  ( 0 % , -15.3 % ) -23.2 %  ( -12.7 % , -32.2 % ) -36.2 %  ( -23.1 % , -47.2 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -3 % )
0.7 0.25 -0.9 %  ( -1.1 % , -0.8 % ) -4.9 %  ( -4.8 % , -4.5 % ) -8.6 %  ( -8 % , -8.3 % ) -14.9 %  ( -13 % , -15.3 % ) -20.3 %  ( -16.6 % , -21.8 % ) -25.5 %  ( -20 % , -29.6 % )
0.7 0.45 -1.2 %  ( -1.4 % , -1.2 % ) -9.4 %  ( -10.2 % , -8.5 % ) -16.2 %  ( -16.8 % , -14.7 % ) -26.2 %  ( -25.7 % , -24.9 % ) -33.9 %  ( -31.9 % , -33.5 % ) -41.7 %  ( -37.1 % , -42.3 % )
0.7 0.65 0 %  ( 0 % , 0 % ) -3.1 %  ( 0 % , -12.6 % ) -16.8 %  ( -9.2 % , -24.9 % ) -35.2 %  ( -26 % , -42 % ) -47.3 %  ( -36.5 % , -54.2 % ) -57.9 %  ( -45 % , -67.2 % )




Additional analyses - Fully Endemic scenario 
The absolute difference between the median and 95% credible interval (CrI) of the static and dynamic models’ 
predictions of the lowest level of condom consistency tolerated over the time horizon for the additional scenario 
Fully Endemic (PrEP introduced in 2030) is shown in Table S7. 
 
Fully Endemic Scenario 
 
 
Table S7: Absolute difference between the static and dynamic models’ prediction of the lowest level of 
condom consistency tolerated, when the dynamic model is run over a time horizon of 3 months to 20 years, 
under the Fully Endemic scenario. The values stated outside the brackets are the absolute difference between 
the median values predicted by the static and dynamic models, and the values in the left and right of the bracket 
are the absolute difference between the lower and upper 95% credible intervals predicted by the static and 
dynamic models respectively.  
 
  






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.25 0.2 %  ( 0.2 % , 0.1 % ) -0.7 %  ( -1.2 % , -0.8 % ) -1.7 %  ( -1.8 % , -1.9 % ) -3.2 %  ( -2.3 % , -4.5 % ) -4.5 %  ( -2.2 % , -6.8 % ) -5.5 %  ( -2 % , -9.7 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -3.4 % ) -0.6 %  ( 0 % , -6.9 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 0.1 %  ( 0.2 % , 0.1 % ) -0.6 %  ( -0.6 % , -0.6 % ) -1.4 %  ( -1.1 % , -1.9 % ) -2.7 %  ( -0.9 % , -5.3 % ) -3.4 %  ( -0.2 % , -8.3 % ) -4.3 %  ( -0.1 % , -12.3 % )
0.5 0.45 0.2 %  ( 0.2 % , 0.2 % ) -2.8 %  ( -3.3 % , -2.3 % ) -5.4 %  ( -6.3 % , -4.7 % ) -9.6 %  ( -10.5 % , -9.3 % ) -12.5 %  ( -12 % , -14.1 % ) -14.9 %  ( -13.4 % , -19.7 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -1.8 % ) -0.1 %  ( 0 % , -7.9 % ) -4.8 %  ( 0 % , -14.4 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.7 0.25 0.2 %  ( 0 % , 0.2 % ) -0.3 %  ( -0.3 % , -0.2 % ) -0.9 %  ( -0.3 % , -1.4 % ) -1.5 %  ( 0 % , -5 % ) -2.1 %  ( 0.9 % , -8.3 % ) -2.5 %  ( 1.5 % , -11.8 % )
0.7 0.45 0.2 %  ( 0.1 % , 0.2 % ) -1.8 %  ( -2.4 % , -1.4 % ) -3.8 %  ( -4.4 % , -2.9 % ) -7 %  ( -6.9 % , -7.3 % ) -9.1 %  ( -8.6 % , -11.5 % ) -11.1 %  ( -8.9 % , -16.4 % )
0.7 0.65 0.3 %  ( 0 % , 0.2 % ) -5.9 %  ( -0.9 % , -5 % ) -11.4 %  ( -7.3 % , -9 % ) -19.1 %  ( -16 % , -15.6 % ) -24.2 %  ( -20.5 % , -20.9 % ) -27.9 %  ( -24.3 % , -26.7 % )
0.7 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , -8.8 % )
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Lowest Level of Condom Consistency Tolerated: Tables of percentage change between static 
and dynamic model’s outcomes 
 
The percentage change between the median and 95% credible interval (CrI) of the static and dynamic models’ 
predictions of the lowest level of condom consistency tolerated in absolute terms over the time horizon for both 
the Epidemic Equilibrium and Increasing Epidemic scenarios are shown in Tables S8a and S8b respectively. 
 




Table S8a: Epidemic Equilibrium Scenario: Percentage change between the static and dynamic models’ 
prediction of the lowest level of condom consistency tolerated, when the dynamic model is run over a time 
horizon of 3 months to 20 years. 
 
 
Increasing Epidemic Scenario 
 
 
Table S8b: Increasing Epidemic Scenario: Percentage change between the static and dynamic models’ 
prediction of the lowest level of condom consistency tolerated, when the dynamic model is run over a time 
horizon of 3 months to 20 years.  
 
Tables S8a and S8b respectively show for the scenarios where PrEP is introduced at Epidemic Equilibrium and 
where PrEP is introduced with Increasing Epidemic the percentage change between the static and dynamic 
models’ prediction of the lowest level of condom consistency tolerated in absolute terms, when the dynamic 
model is run over a time horizon of 3 months to 20 years. The percentage change values stated outside the 
brackets are the percentage change between the median values predicted by the static and dynamic models, and 
the values in the left and right of the bracket are the percentage change between the lower and upper 95% 
credible intervals predicted by the static and dynamic models respectively.  






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.25 4.4 %  ( -0.7 % , 0.9 % ) 0 %  ( 2.8 % , -4.3 % ) -5.6 %  ( 9.2 % , -14.5 % ) -10 %  ( 23.5 % , -36.8 % ) -8.9 %  ( 41.1 % , -64.1 % ) -10 %  ( 67.2 % , -105.1 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 0.9 %  ( -2 % , 0.9 % ) 0.9 %  ( 1.7 % , -0.9 % ) 0.9 %  ( 10.7 % , -4.6 % ) 1.5 %  ( 32 % , -13.7 % ) 2.1 %  ( 100 % , -24.3 % ) 3 %  ( 92 % , -39.4 % )
0.5 0.45 2.8 %  ( -1.2 % , 2.6 % ) -13.8 %  ( 3.8 % , -8.3 % ) -25.7 %  ( 10.5 % , -23.1 % ) -47.7 %  ( 26.3 % , -57.7 % ) -64.2 %  ( 100 % , -90.4 % ) -78 %  ( 62.6 % , -137.8 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.7 0.25 0.5 %  ( -1.9 % , 0.3 % ) 0.9 %  ( 1.9 % , -0.3 % ) 1.9 %  ( 7.5 % , -1.4 % ) 3 %  ( 27.5 % , -5.3 % ) 4.2 %  ( 100 % , -11.7 % ) 4.6 %  ( 114.4 % , -21.8 % )
0.7 0.45 1 %  ( -1.1 % , 0.7 % ) -1.8 %  ( 3.2 % , -1.8 % ) -3.8 %  ( 8.4 % , -5 % ) -5.8 %  ( 22.2 % , -12.9 % ) -8.5 %  ( 100 % , -23.4 % ) -10.8 %  ( 66.8 % , -39.2 % )
0.7 0.65 5.5 %  ( 0 % , 1.2 % ) -50.7 %  ( 5.8 % , -18.6 % ) -102.7 %  ( 11.8 % , -37.7 % ) -175.3 %  ( 24.8 % , -79.6 % ) -224.7 %  ( 100 % , -115 % ) -263 %  ( 53.5 % , -170.7 % )
0.7 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 87.5 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 100 % , 0 % )
0.1 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.25 -20.7 %  ( 9.3 % , -13 % ) -98.9 %  ( 50.6 % , -72.4 % ) -165.2 %  ( 89.8 % , -129.3 % ) -270.7 %  ( 100 % , -223.6 % ) -327.2 %  ( 100 % , -287 % ) -263 %  ( 100 % , -291.1 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 41.1 % , 0 % ) 0 %  ( 89.2 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 100 % , 0 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 -3.6 %  ( 7.1 % , -2.8 % ) -19.4 %  ( 40.7 % , -17 % ) -32.4 %  ( 76.8 % , -32.1 % ) -55.2 %  ( 100 % , -58 % ) -67 %  ( 100 % , -76.1 % ) -52.1 %  ( 100 % , -76.4 % )
0.5 0.45 -13.9 %  ( 3.5 % , -7.5 % ) -100.9 %  ( 27.8 % , -59.4 % ) -166.7 %  ( 48.5 % , -103.1 % ) -263 %  ( 83.2 % , -176.9 % ) -315.7 %  ( 100 % , -226.3 % ) -274.1 %  ( 100 % , -233.1 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 52.4 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 76.1 % , 0 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.7 0.25 -1.4 %  ( 4.5 % , -0.8 % ) -7.6 %  ( 31.2 % , -5.8 % ) -12.7 %  ( 61.1 % , -11.4 % ) -21.5 %  ( 100 % , -22.5 % ) -26.9 %  ( 100 % , -30.7 % ) -21.1 %  ( 100 % , -33.2 % )
0.7 0.45 -2.3 %  ( 2.2 % , -1.3 % ) -18.5 %  ( 22.6 % , -12.8 % ) -31.4 %  ( 39.9 % , -22.6 % ) -51.1 %  ( 73.6 % , -41.9 % ) -61.8 %  ( 100 % , -57 % ) -55.2 %  ( 100 % , -61 % )
0.7 0.65 -18.1 %  ( 0 % , -5.1 % ) -205.6 %  ( 21.6 % , -63.3 % ) -326.4 %  ( 36.8 % , -109 % ) -504.2 %  ( 59.8 % , -176.8 % ) -597.2 %  ( 100 % , -222 % ) -556.9 %  ( 81.7 % , -241.2 % )
0.7 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 0 % , 0 % )
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Additional analyses – Structural sensitivity analysis 
The percentage change between the median and 95% credible interval (CrI) of the static and dynamic models’ 
predictions of the lowest level of condom consistency tolerated in absolute terms over the time horizon for both 
the Epidemic Equilibrium and Increasing Epidemic scenarios for the structural sensitivity analysis are shown in 
Tables S9a andS 9b respectively. 
 
Structural Sensitivity Analysis 




Table S9a: Structural sensitivity analysis: Epidemic Equilibrium Scenario: Percentage change between the 
static and dynamic models’ prediction of the lowest level of condom consistency tolerated, when the dynamic 
model is run over a time horizon of 3 months to 20 years. 
 
 
Structural Sensitivity Analysis 
Increasing Epidemic Scenario 
 
Table S9b: Structural sensitivity analysis: Increasing Epidemic Scenario: Percentage change between the 
static and dynamic models’ prediction of the lowest level of condom consistency tolerated, when the dynamic 
model is run over a time horizon of 3 months to 20 years. 
 
Tables S9a and S9b respectively show, for the scenarios where PrEP is introduced at Epidemic Equilibrium 
and where PrEP is introduced with Increasing Epidemic under the structural sensitivity analysis, the 
percentage change between the static and dynamic models’ prediction of the lowest level of condom consistency 
tolerated in absolute terms, when the dynamic model is run over a time horizon of 3 months to 20 years. The 
percentage change values stated outside the brackets are the percentage change between the median values 
predicted by the static and dynamic models, and the values in the left and right of the bracket are the percentage 
change between the lower and upper 95% credible intervals predicted by the static and dynamic models 
respectively.  
 






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.25 -33.3 %  ( 0 % , -10.7 % ) -533.3 %  ( 11.6 % , -114.3 % ) -983.3 %  ( 23.7 % , -232.1 % ) -1700 %  ( 45.3 % , -439.3 % ) -2183.3 %  ( 100 % , -621.4 % ) -2450 %  ( 82.6 % , -803.6 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 -0.4 %  ( 0.5 % , -0.3 % ) -7.3 %  ( 10.7 % , -7.5 % ) -13.9 %  ( 22.7 % , -15.9 % ) -24.8 %  ( 49.8 % , -34.6 % ) -32.8 %  ( 100 % , -53.6 % ) -38.3 %  ( 109 % , -75.6 % )
0.5 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 20 % , 0 % ) 0 %  ( 37.9 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 70.8 % , 0 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.7 0.25 0.2 %  ( 0 % , 0 % ) -1.7 %  ( 8 % , -2 % ) -3.5 %  ( 20.1 % , -4.8 % ) -6.5 %  ( 47.7 % , -11.8 % ) -8.9 %  ( 100 % , -22.5 % ) -11.1 %  ( 139.2 % , -34.4 % )
0.7 0.45 0.3 %  ( 0 % , 0 % ) -9.7 %  ( 8.6 % , -8.1 % ) -19.4 %  ( 17.4 % , -16.5 % ) -35.8 %  ( 36.6 % , -34.9 % ) -46.5 %  ( 100 % , -52.8 % ) -55.2 %  ( 78.7 % , -75.1 % )
0.7 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 29.8 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 57.4 % , 0 % )
0.7 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 100 % , 0 % )
0.1 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % )
0.1 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.25 -385.7 %  ( 9.9 % , -96.4 % ) -1814.3 %  ( 48.7 % , -471.4 % )-3000 %  ( 81.8 % , -796.4 % ) 4771.4 %  ( 100 % , -1285.7 % 6057.1 %  ( 100 % , -1685.7 % -7100 %  ( 100 % , -2035.7 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 68.9 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 100 % , 0 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 90.6 % , 0 % )
0.3 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 -5.8 %  ( 8 % , -5.4 % ) -30.5 %  ( 42 % , -29.6 % ) -52.4 %  ( 73.8 % , -51.7 % ) -88 %  ( 100 % , -89.5 % ) -113.8 %  ( 100 % , -117.7 % ) -137.8 %  ( 100 % , -145.9 % )
0.5 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 30 % , 0 % ) 0 %  ( 50.7 % , 0 % ) 0 %  ( 82.6 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 100 % , 0 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 94.3 % , 0 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.7 0.25 -1.7 %  ( 6.1 % , -1.4 % ) -9.1 %  ( 32.8 % , -8 % ) -16 %  ( 60.6 % , -14.8 % ) -27.6 %  ( 100 % , -27.2 % ) -37.7 %  ( 100 % , -38.8 % ) -47.3 %  ( 100 % , -52.7 % )
0.7 0.45 -3.9 %  ( 3.3 % , -3.3 % ) -30.8 %  ( 24.9 % , -23.6 % ) -53.1 %  ( 43.1 % , -40.8 % ) -85.9 %  ( 73.2 % , -69.2 % ) -111.1 %  ( 100 % , -93.1 % ) -136.7 %  ( 100 % , -117.5 % )
0.7 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 35.6 % , 0 % ) 0 %  ( 60 % , 0 % ) 0 %  ( 100 % , 0 % ) 0 %  ( 95.9 % , 0 % )




Additional analyses - Fully Endemic scenario 
The percentage change between the median and 95% credible interval (CrI) of the static and dynamic models’ 
predictions of the lowest level of condom consistency tolerated in absolute terms over the time horizon for the 
additional scenario Fully Endemic (PrEP introduced in 2030) is shown in Table 10. 
 
Fully Endemic Scenario 
 
 
Table S10: Percentage change between the static and dynamic models’ prediction of the lowest level of 
condom consistency tolerated, when the dynamic model is run over a time horizon of 3 months to 20 years, 
under the Fully Endemic scenario. The percentage change values stated outside the brackets are the 
percentage change between the median values predicted by the static and dynamic models, and the values in the 
left and right of the bracket are the percentage change between the lower and upper 95% credible intervals 
predicted by the static and dynamic models respectively.  
 
  






3 months 1 year 2 years 5 years 10 years 20 years
0.1 0.25 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.1 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.25 2.1 %  ( -1 % , 0.8 % ) -7.4 %  ( 4.2 % , -6.7 % ) -17.9 %  ( 10.3 % , -16 % ) -33.7 %  ( 24.6 % , -37.8 % ) -47.4 %  ( 100 % , -57.1 % ) -57.9 %  ( 53.3 % , -81.5 % )
0.3 0.45 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.3 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.25 0.3 %  ( -1 % , 0.3 % ) -1.8 %  ( 4 % , -1.7 % ) -4.3 %  ( 12 % , -5.4 % ) -8.2 %  ( 35.1 % , -15.1 % ) -10.3 %  ( 100 % , -23.7 % ) -13.1 %  ( 81.6 % , -35.1 % )
0.5 0.45 1.9 %  ( -0.4 % , 1.3 % ) -26.7 %  ( 6.7 % , -14.6 % ) -51.4 %  ( 13.6 % , -29.9 % ) -91.4 %  ( 27 % , -59.2 % ) -119 %  ( 100 % , -89.8 % ) -141.9 %  ( 57.4 % , -125.5 % )
0.5 0.65 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.5 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
0.7 0.25 0.4 %  ( -1.3 % , 0.3 % ) -0.5 %  ( 2.5 % , -0.3 % ) -1.6 %  ( 13.2 % , -2.4 % ) -2.6 %  ( 44.7 % , -8.5 % ) -3.7 %  ( 100 % , -14.1 % ) -4.4 %  ( 106.3 % , -20 % )
0.7 0.45 0.5 %  ( -0.8 % , 0.5 % ) -4.6 %  ( 5.4 % , -3.2 % ) -9.7 %  ( 11.4 % , -6.6 % ) -17.9 %  ( 28.5 % , -16.5 % ) -23.3 %  ( 100 % , -26 % ) -28.4 %  ( 63.7 % , -37.1 % )
0.7 0.65 4.9 %  ( 0 % , 1.2 % ) -96.7 %  ( 9.4 % , -29.4 % ) -186.9 %  ( 16.9 % , -52.9 % ) -313.1 %  ( 29.5 % , -91.8 % ) -396.7 %  ( 100 % , -122.9 % ) -457.4 %  ( 50.5 % , -157.1 % )
0.7 0.85 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % ) 0 %  ( 0 % , 0 % )
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Additional assessment of results 
Comparison of static and dynamic model outcomes 
Under the scenario that PrEP is introduced at HIV Epidemic Equilibrium, the static and dynamic models predict 
very closely at 3 months (<5% relative difference between medians, and <5% relative difference between model 
95% credible intervals (CrIs) - see Supplementary Materials Tables S2a and S2b), and predict fairly consistently 
up to a time horizon of 1 year (<10% relative difference between the median and 95% CrI predictions). After 5 
years, the relative difference between the median model predictions is less than 25% (<35% relative difference 
between their 95% CrIs); and after 20 years the relative difference between the median model outcomes grows 
to up to 35% (up to 100% relative difference their 95% CrIs). 
The model outcomes are more consistent over time at lower levels of initial condom consistency (≤30%), where 
the relative difference between median predictions is less than 5% (up to 70% relative difference between 95% 
CrIs) over the 20-year time horizon. Where both initial condom consistency is low (≤30%) and PrEP use-
effectiveness is high (≥65%), there is no change between the models’ median predictions (100% relative 
difference between their 95% CrIs from 10 years). The differences between the models are more pronounced 
over time where initial condom consistencies are higher (≥50%) and the levels of PrEP use-effectiveness 
achieved are lower (≤45%).  
Under the Increasing Epidemic scenario, the comparison between static and dynamic models follow a similar 
trend to those under the Epidemic Equilibrium scenario, however the differences between the models are more 
pronounced over time. After 1 year the relative difference between the model medians is up to 45% and up to 
55% between the 95% CrIs (in comparison to a relative difference of no more than 10% between the medians 
and 95% CrIs under the Epidemic Equilibrium scenario), and by 5 years, the relative difference between the 
models is up to 100% (in comparison to less than 25% between model medians and less than 35% between 
model 95% CrIs under the Epidemic Equilibrium scenario). After 20 years the differences between the models 
starts to decrease in response to the natural plateau and slight decline of the underlying HIV epidemics 
(Supplementary Materials Table S2b).  
Under the Epidemic Equilibrium scenario, at the lower and upper bounds of initial condom consistencies 
explored (10% and 70%) and where PrEP use-effectiveness is 85% (i.e. the maximum assumed use-
effectiveness of condoms35,36), the minimum and maximum whiskers do not protrude from the interquartile 
ranges of the box plots, indicating reasonable consistency of results across the model fits. By contrast, under the 
Increasing Epidemic scenario, the minimum and maximum whiskers protrude from the interquartile ranges of 
the boxplots, other than where PrEP use-effectiveness is 85% and initial condom consistency is low (≤30%), 
indicating increased variance in the results across model fits in comparison to the Epidemic Equilibrium 
scenario. 
 
Additional analyses – structural sensitivity analysis 
Removing the risk parameters relating to ART, circumcision and STIs from the models affects the difference 
between the percentage reduction in condom consistency tolerated predicted by the static and dynamic models 
in certain conditions. Under the Epidemic Equilibrium scenario, the notable differences can be seen for initial 
condom consistencies of 30% upwards and at lower levels of PrEP use-effectiveness (≤45%), where the 
differences between the two models’ estimates of percentage reduction in condom consistency tolerated is 
greater over time (<35% relative difference between model medians and <45% between CrIs by 5 years, and 
<50% relative difference between medians and CrIs by 20 years) (Supplementary Materials Figure S6 vs. 
Figure S10, and Table S2a vs. Table S3a). This is likely in response to differences in the underlying epidemic 
trajectories, which level out more quickly where these parameters are not included in the models (as the 
epidemic curves do not see the same slight dip after 2014 when male circumcision and ART are assumed to 
have reached their highest scale-up coverage), but slightly decrease under the base case. Accordingly, the 
slightly higher levels of underlying HIV prevalence in the former scenario result in increased HIV risk over time 
in the dynamic model in the cases where there is less protection (i.e. lower levels of PrEP and greater absolute 
drops in condom consistency). 
35 
 
Under the Increasing Epidemic scenario, the notable differences are more pronounced at higher levels of initial 
condom consistency (≥50%) and higher levels of PrEP use-effectiveness (≥65%) (<25% relative difference 
between model medians and CrIs by 5 years, and <30% relative difference between model medians and <35% 
between CrIs by 20 years for the Increasing Epidemic scenario) (Supplementary Materials Figure S8 and 
Figure S11, and Table S2b vs. Table S3b). Similarly, this is likely in response to differences in the underlying 
epidemic trajectories, which continue to slightly increase over time after levelling out around 2010 where these 
parameters are not included in the models, but level out more evenly under the base case. For the same reasons, 
unlike under the base analysis, where after 20 years the differences between the models starts to decrease in 
response to the natural plateau of the underlying HIV epidemics, the same is not true where the specified risk 
parameters are removed from the equations, in which case the underlying epidemics instead slightly increase 
over time. 
 
Additional analyses - Fully Endemic scenario 
Introducing PrEP at 2030 when the underlying HIV epidemics are fully endemic in the populations, as opposed 
to in 2015 when they have just started to stabilise has little effect on the differences between the percentage 
reduction in condom consistency tolerated predicted by the static and dynamic models. The main differences are 
that at low levels of PrEP use-effectiveness (25%), the differences between the models are slightly greater under 
the Fully Settled Epidemic scenario (up to 25% difference between absolute medians), and whilst the 
interquartile ranges are narrower under the Fully Settled Epidemic scenario, the 95% CrIs are slightly wider 
under this scenario likely owing to greater uncertainty in epidemic pathways further out in time (Supplementary 
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